Exact Mass: 315.1596

Exact Mass Matches: 315.1596

Found 500 metabolites which its exact mass value is equals to given mass value 315.1596, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Oxycodone

(1S,5R,13R,17S)-17-hydroxy-10-methoxy-4-methyl-12-oxa-4-azapentacyclo[9.6.1.0^{1,13}.0^{5,17}.0^{7,18}]octadeca-7(18),8,10-trien-14-one

C18H21NO4 (315.1471)


Oxycodone is only found in individuals that have used or taken this drug. It is a semisynthetic derivative of codeine that acts as a narcotic analgesic more potent and addicting than codeine. [PubChem]Oxycodone acts as a weak agonist at mu, kappa, and delta opioid receptors within the central nervous system (CNS). Oxycodone primarily affects mu-type opioid receptors, which are coupled with G-protein receptors and function as modulators, both positive and negative, of synaptic transmission via G-proteins that activate effector proteins. Binding of the opiate stimulates the exchange of GTP for GDP on the G-protein complex. As the effector system is adenylate cyclase and cAMP located at the inner surface of the plasma membrane, opioids decrease intracellular cAMP by inhibiting adenylate cyclase. Subsequently, the release of nociceptive neurotransmitters such as substance P, GABA, dopamine, acetylcholine, and noradrenaline is inhibited. Opioids such as oxycodone also inhibit the release of vasopressin, somatostatin, insulin, and glucagon. Opioids close N-type voltage-operated calcium channels (kappa-receptor agonist) and open calcium-dependent inwardly rectifying potassium channels (mu and delta receptor agonist). This results in hyperpolarization and reduced neuronal excitability. D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D009294 - Narcotics D002492 - Central Nervous System Depressants > D009294 - Narcotics > D053610 - Opiate Alkaloids N - Nervous system > N02 - Analgesics > N02A - Opioids > N02AA - Natural opium alkaloids D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist D002491 - Central Nervous System Agents > D000700 - Analgesics

   

(S)-3-Hydroxy-N-methylcoclaurine

4-{[(1S)-7-hydroxy-6-methoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-1-yl]methyl}benzene-1,2-diol

C18H21NO4 (315.1471)


(S)-3-Hydroxy-N-methylcoclaurine is an intermediate in the biosynthesis of alkaloids (KEGG ID C05202). It is the 10th to last step in the synthesis of morphine and is converted from (s)-N-methylcoclaurine via the enzyme tyrosinase [EC:1.14.18.1]. It is then converted to (S)-reticuline. [HMDB] (S)-3-Hydroxy-N-methylcoclaurine is an intermediate in the biosynthesis of alkaloids (KEGG ID C05202). It is the 10th to last step in the synthesis of morphine and is converted from (s)-N-methylcoclaurine via the enzyme tyrosinase [EC:1.14.18.1]. It is then converted to (S)-reticuline.

   

Nororientaline

Nororientaline

C18H21NO4 (315.1471)


An isoquinoline alkaloid consisting of a tetrahydroisoquinoline core with 4-hydroxy-3-methoxybenzyl, methoxy and hydroxy substituents at positions 1, 6 and 7 respectively; major species at pH 7.3.

   

Norreticuline

(R)-Norreticuline

C18H21NO4 (315.1471)


   

Belladine

Belladine

C19H25NO3 (315.1834)


A phenethylamine alkaloid that is N-methyl-4-methoxyphenylethylamine carrying an additional N-(3,4-dimethoxybenzyl) substituent.

   

Cephalotaxine

Cephalotaxine

C18H21NO4 (315.1471)


Cephalotaxlen ((-)-Cephalotaxine) is an alkaloid that can be isolated from Cephalotaxus fortunei, with antileukemic and antiviral activities. Cephalotaxlen has anti-ZIKV (Zika virus) activity[1][2][3]. Cephalotaxlen ((-)-Cephalotaxine) is an alkaloid that can be isolated from Cephalotaxus fortunei, with antileukemic and antiviral activities. Cephalotaxlen has anti-ZIKV (Zika virus) activity[1][2][3].

   

2-Nitroestrone

3-Hydroxy-2-nitroestra-1,3,5(10)-trien-17-one

C18H21NO4 (315.1471)


   

4-Nitroestrone

3-Hydroxy-4-nitroestra-1,3,5(10)-trien-17-one

C18H21NO4 (315.1471)


   

Neosaxitoxin

[(4R,10aS,10bS)-2-amino-5,10,10-trihydroxy-6-imino-3H,4H,5H,6H,8H,9H,10H,10bH-pyrrolo[1,2-c]purin-4-yl]methyl carbamate

C10H17N7O5 (315.1291)


D018373 - Peripheral Nervous System Agents > D009465 - Neuromuscular Agents > D009466 - Neuromuscular Blocking Agents Neosaxitoxin is produced by Protogonyaulax and found in shellfis D009676 - Noxae > D011042 - Poisons > D008978 - Mollusk Venoms D009676 - Noxae > D011042 - Poisons > D008387 - Marine Toxins D009676 - Noxae > D011042 - Poisons > D014688 - Venoms D010575 - Pesticides > D007306 - Insecticides D016573 - Agrochemicals

   

Clavamycin D

Antibiotic CA 146A

C13H21N3O6 (315.143)


   

Alizapride

6-methoxy-N-{[1-(prop-2-en-1-yl)pyrrolidin-2-yl]methyl}-2H-1,2,3-benzotriazole-5-carboxamide

C16H21N5O2 (315.1695)


D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents C78272 - Agent Affecting Nervous System > C267 - Antiemetic Agent D005765 - Gastrointestinal Agents > D000932 - Antiemetics D002491 - Central Nervous System Agents

   

(S)-Norreticuline

(S)-Norreticuline

C18H21NO4 (315.1471)


   

(S)-Nororientaline

(S)-Nororientaline

C18H21NO4 (315.1471)


   

Codeine N-oxide

14-hydroxy-10-methoxy-4-methyl-12-oxa-4λ⁵-azapentacyclo[9.6.1.0¹,¹³.0⁵,¹⁷.0⁷,¹⁸]octadeca-7(18),8,10,15-tetraen-4-one

C18H21NO4 (315.1471)


Codeine N-oxide is found in opium poppy. Codeine N-oxide is an alkaloid from Papaver somniferum (opium poppy). Alkaloid from Papaver somniferum (opium poppy). Codeine N-oxide is found in opium poppy.

   

(E)-Piperolein A

(6E)-7-(2H-1,3-benzodioxol-5-yl)-1-(piperidin-1-yl)hept-6-en-1-one

C19H25NO3 (315.1834)


(e)-piperolein a is a member of the class of compounds known as benzodioxoles. Benzodioxoles are organic compounds containing a benzene ring fused to either isomers of dioxole. Dioxole is a five-membered unsaturated ring of two oxygen atoms and three carbon atoms (e)-piperolein a is practically insoluble (in water) and an extremely weak basic (essentially neutral) compound (based on its pKa). (e)-piperolein a can be found in herbs and spices, which makes (e)-piperolein a a potential biomarker for the consumption of this food product. (E)-Piperolein A is found in herbs and spices. (E)-Piperolein A is a minor constituent of Piper nigrum (pepper

   

(±)-Pandamarine

3-methyl-6-{4-[(2E)-4-methyl-5-oxo-2,5-dihydro-1H-pyrrol-2-ylidene]butyl}-1,6-diazaspiro[4.5]dec-3-en-2-one

C18H25N3O2 (315.1947)


(±)-Pandamarine is a major alkaloid from leaves of Pandanus amaryllifolius. Major alkaloid from leaves of Pandanus amaryllifolius

   

N-Dihydroferuloyltyramine

3-(4-Hydroxy-3-methoxyphenyl)-N-[2-(4-hydroxyphenyl)ethyl]propanimidate

C18H21NO4 (315.1471)


N-Dihydroferuloyltyramine is found in fruits. N-Dihydroferuloyltyramine is an alkaloid from stems of cherimoya (Annona cherimola). Alkaloid from stems of cherimoya (Annona cherimola). N-Dihydroferuloyltyramine is found in fruits.

   

Erythratine

19-methoxy-5,7-dioxa-13-azapentacyclo[11.7.0.0¹,¹⁶.0²,¹⁰.0⁴,⁸]icosa-2,4(8),9,16-tetraen-18-ol

C18H21NO4 (315.1471)


Erythratine is found in green vegetables. Erythratine is an alkaloid from the seeds of Erythrina glauca (gallito

   

Mitiglinide

Calcium 2-benzyl-3-(cis-hexahydro-2-isoindolinylcarbonyl)propionate dihydrate

C19H25NO3 (315.1834)


Mitiglinide is only found in individuals that have used or taken this drug. It is a drug for the treatment of type 2 diabetes.Mitiglinide is thought to stimulate insulin secretion by binding to and blocking ATP-sensitive K(+) (K(ATP)) channels (Kir6.2/SUR1 complex, KATP channels) in pancreatic beta-cells. Closure of potassium channels causes depolarization which stimulates calcium influx through voltage-gated calcium channels. High intracellular calcium subsequently triggers the exocytosis of insulin granules.

   

Alizapride

6-methoxy-N-{[1-(prop-2-en-1-yl)pyrrolidin-2-yl]methyl}-2H-1,2,3-benzotriazole-5-carboxamide

C16H21N5O2 (315.1695)


Alizapride is only found in individuals that have used or taken this drug. It is a dopamine antagonist with prokinetic and antiemetic effects used in the treatment of nausea and vomiting, including postoperative nausea and vomiting.The anti-emetic action of Alizapride is due to its antagonist activity at D2 receptors in the chemoreceptor trigger zone (CTZ) in the central nervous system (CNS)—this action prevents nausea and vomiting triggered by most stimuli. Structurally similar to metoclopramide and, therefore, shares similar other atributres related to emesis and prokinetics. D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents C78272 - Agent Affecting Nervous System > C267 - Antiemetic Agent D005765 - Gastrointestinal Agents > D000932 - Antiemetics D002491 - Central Nervous System Agents

   

Rotigotine

6-{propyl[2-(thiophen-2-yl)ethyl]amino}-5,6,7,8-tetrahydronaphthalen-1-ol

C19H25NOS (315.1657)


Rotigotine (Neupro) is a non-ergoline dopamine agonist indicated for the treatment of Parkinsons disease (PD) and restless legs syndrome (RLS) in Europe and the United States. It is formulated as a once-daily transdermal patch which provides a slow and constant supply of the drug over the course of 24 hours. Like other dopamine agonists, rotigotine has been shown to possess antidepressant effects and may be useful in the treatment of depression as well. Rotigotine was developed by Aderis Pharmaceuticals. In 1998, Aderis licensed worldwide development and commercialization rights for rotigotine to the German pharmaceutical company Schwarz Pharma (today a subsidiary of the Belgian company UCB S.A.). The drug has been approved by the EMEA for use in Europe in 2006 and is today being sold in several European countries. In 2007, the Neupro patch was approved by the Food and Drug Administration (FDA) as the first transdermal treatment of Parkinsons disease in the United States. However, as of 2008, Schwarz Pharma has recalled all Neupro patches in the United States and some in Europe because of problems with the delivery mechanism. Rotigotine has been authorized as a treatment for RLS since August 2008. D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018491 - Dopamine Agonists

   

Saxagliptin

(1S,3S,5S)-2-((2S)-Amino(3-hydroxytricyclo(3.3.1.13,7)dec-1-yl)acetyl)-2-azabicyclo(3.1.0)hexane-3-carbonitrile

C18H25N3O2 (315.1947)


Saxagliptin (rINN), previously identified as BMS-477118, is a new oral hypoglycemic (anti-diabetic drug) of the new dipeptidyl peptidase-4 (DPP-4) inhibitor class of drugs. It was developed by Bristol-Myers Squibb. A New Drug Application for saxagliptin in the treatment of type 2 diabetes was submitted to the FDA in June 2008. It was based on a drug development program with 8 randomized trials: 1 phase 2 dose-ranging (2.5 - 100 mg/d) study; 6 phase 3, 24-week controlled trials with additional controlled follow-up from 12 to 42 months, double-blinded throughout; and one 12-week mechanism-of-action trial with a 2-year follow-up period. In June 2008, it was announced that Onglyza would be the trade name under which saxagliptin will be marketed. A - Alimentary tract and metabolism > A10 - Drugs used in diabetes > A10B - Blood glucose lowering drugs, excl. insulins > A10BH - Dipeptidyl peptidase 4 (dpp-4) inhibitors C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent > C98086 - Dipeptidyl Peptidase-4 Inhibitor D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D054795 - Incretins D007004 - Hypoglycemic Agents > D054873 - Dipeptidyl-Peptidase IV Inhibitors D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors C471 - Enzyme Inhibitor > C783 - Protease Inhibitor

   

N'-Hydroxysaxitoxin

{10,10-dihydroxy-2,6-diimino-hexahydro-1H-pyrrolo[1,2-c]purin-4-yl}methyl N-hydroxycarbamate

C10H17N7O5 (315.1291)


N-Hydroxysaxitoxin is isolated from the crab Zosimus aeneus. Isolated from the crab Zosimus aeneus.

   

(6Z)-Oct-6-enedioylcarnitine

3-[(7-carboxyhept-6-enoyl)oxy]-4-(trimethylazaniumyl)butanoate

C15H25NO6 (315.1682)


(6Z)-oct-6-enedioylcarnitine is an acylcarnitine. More specifically, it is an (6Z)-oct-6-enedioic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. (6Z)-oct-6-enedioylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine (6Z)-oct-6-enedioylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

Oct-4-enedioylcarnitine

3-[(7-carboxyhept-4-enoyl)oxy]-4-(trimethylazaniumyl)butanoate

C15H25NO6 (315.1682)


oct-4-enedioylcarnitine is an acylcarnitine. More specifically, it is an oct-4-enedioic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. oct-4-enedioylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine oct-4-enedioylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

Oct-5-enedioylcarnitine

3-[(7-carboxyhept-5-enoyl)oxy]-4-(trimethylazaniumyl)butanoate

C15H25NO6 (315.1682)


oct-5-enedioylcarnitine is an acylcarnitine. More specifically, it is an oct-5-enedioic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. oct-5-enedioylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine oct-5-enedioylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

(2E)-Oct-2-enedioylcarnitine

3-[(7-carboxyhept-2-enoyl)oxy]-4-(trimethylazaniumyl)butanoate

C15H25NO6 (315.1682)


(2E)-oct-2-enedioylcarnitine is an acylcarnitine. More specifically, it is an (2E)-oct-2-enedioic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. (2E)-oct-2-enedioylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine (2E)-oct-2-enedioylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

(2R,3R,6S)-4-Methoxy-16,18-dioxa-10-azapentacyclo[11.7.0.02,6.06,10.015,19]icosa-1(20),4,13,15(19)-tetraen-3-ol

(2R,3R,6S)-4-Methoxy-16,18-dioxa-10-azapentacyclo[11.7.0.02,6.06,10.015,19]icosa-1(20),4,13,15(19)-tetraen-3-ol

C18H21NO4 (315.1471)


   

6-Amino-9-benzyl-2-(2-methoxyethoxy)-9H-purin-8-ol

6-amino-9-benzyl-2-(2-methoxyethoxy)-8,9-dihydro-7H-purin-8-one

C15H17N5O3 (315.1331)


   

Di-deacetyl adrogolide

15-propyl-14-thia-11-azatetracyclo[8.7.0.0^{2,7}.0^{13,17}]heptadeca-2,4,6,13(17),15-pentaene-4,5-diol

C18H21NO2S (315.1293)


   

Dihydroethidium

5-ethyl-6-phenyl-5,6-dihydrophenanthridine-3,8-diamine

C21H21N3 (315.1735)


   

Indicine-N-oxide

7-({[2,3-dihydroxy-2-(propan-2-yl)butanoyl]oxy}methyl)-1-hydroxy-1,2,3,4,5,7a-hexahydropyrrolizin-4-ium-4-olate

C15H25NO6 (315.1682)


   

Synribo

(1S-(1.ALPHA.,3AS*,14B.BETA.))-1,5,6,8,9,14B-HEXAHYDRO-2-METHOXY-4H-CYCLOPENTA(A)(1,3)DIOXOLO(4,5-H)PYRROLO(2,1-B)(3)BENZAZEPIN-1-OL

C18H21NO4 (315.1471)


Cephalotaxine is a benzazepine alkaloid isolated from Cephalotaxus harringtonia. It is a benzazepine alkaloid, a benzazepine alkaloid fundamental parent, an organic heteropentacyclic compound, an enol ether, a cyclic acetal, a secondary alcohol and a tertiary amino compound. Omacetaxine is a semisynthetic cephataxine that acts as a protein translation inhibitor and is used to treated chronic myeloid leukemia that is resistant to tyrosine kinase receptor antagonists. Omacetaxine is associated with a low rate of serum enzyme elevation during therapy, but has not been linked to cases of clinically apparent liver injury with jaundice. Cephalotaxine is a natural product found in Cephalotaxus hainanensis, Cephalotaxus harringtonia, and other organisms with data available. Omacetaxine is a protein translation inhibitor and cytotoxic plant alkaloid homoharringtonine isolated from the evergreen tree Cephalotaxus, with potential antineoplastic activity. Although the exact mechanism of action has not been fully elucidated, upon administration, omacetaxine targets and binds to the 80S ribosome in eukaryotic cells and inhibits protein synthesis by interfering with chain elongation. This reduces levels of certain oncoproteins and anti-apoptotic proteins. Semisynthetic derivative of harringtonine that acts as a protein synthesis inhibitor and induces APOPTOSIS in tumor cells. It is used in the treatment of MYELOID LEUKEMIA, CHRONIC. See also: Omacetaxine Mepesuccinate (active moiety of). D000970 - Antineoplastic Agents > D000972 - Antineoplastic Agents, Phytogenic > D006248 - Harringtonines C274 - Antineoplastic Agent > C2122 - Cell Differentiating Agent > C1934 - Differentiation Inducer D004791 - Enzyme Inhibitors > D011500 - Protein Synthesis Inhibitors C274 - Antineoplastic Agent > C1931 - Antineoplastic Plant Product A benzazepine alkaloid isolated from Cephalotaxus harringtonia. C1907 - Drug, Natural Product Cephalotaxlen ((-)-Cephalotaxine) is an alkaloid that can be isolated from Cephalotaxus fortunei, with antileukemic and antiviral activities. Cephalotaxlen has anti-ZIKV (Zika virus) activity[1][2][3]. Cephalotaxlen ((-)-Cephalotaxine) is an alkaloid that can be isolated from Cephalotaxus fortunei, with antileukemic and antiviral activities. Cephalotaxlen has anti-ZIKV (Zika virus) activity[1][2][3].

   

Indicine N-oxide

Indicine N-oxide

C15H25NO6 (315.1682)


   
   
   
   

(E)-(4-Hydroxycinnamoyl)-epilupinine

(E)-(4-Hydroxycinnamoyl)-epilupinine

C19H25NO3 (315.1834)


   

Bisdehydroneostemonine

Bisdehydroneostemonine

C18H21NO4 (315.1471)


   
   

(+)-11alpha-Hydroxyerythravine

(+)-11alpha-Hydroxyerythravine

C18H21NO4 (315.1471)


   

1-O-Acetylnorpluviine

1-O-Acetyl-9-O-demethylpluviine

C18H21NO4 (315.1471)


   

Stephaoxocanine

Stephaoxocanine

C18H21NO4 (315.1471)


   

O-Methyloduline

O-Methyloduline

C18H21NO4 (315.1471)


   
   

O-methylbalsamide

(+)-O-methylbalsamide

C18H21NO4 (315.1471)


   

9,10-Dimethoxy-1-methyllycorenan-7-one #

9,10-Dimethoxy-1-methyllycorenan-7-one #

C18H21NO4 (315.1471)


   
   

1-Carboxytrypargine

1-Carboxytrypargine

C16H21N5O2 (315.1695)


   

Dihydroperfamine

Dihydroperfamine

C18H21NO4 (315.1471)


   
   

(-)-Stepharinosine

(-)-Stepharinosine

C18H21NO4 (315.1471)


   

Haiderine

O-Demethylhirsutine

C18H21NO4 (315.1471)


   
   

Isocephalotaxine

Isocephalotaxine

C18H21NO4 (315.1471)


   

(+)-Dihydroperfamine

(+)-Dihydroperfamine

C18H21NO4 (315.1471)


   

18,19-Dihydroangustine

18,19-Dihydroangustine

C20H17N3O (315.1372)


   

(S)-3-Hydroxy-N-methylcoclaurine

(S)-3-Hydroxy-N-methylcoclaurine

C18H21NO4 (315.1471)


An isoquinoline alkaloid having a tetrahydroisoquinoline core with 3,4-dihydroxybenzyl, methoxy and hydroxy groups at the 1-, 6- and 7-positions respectively; major species at pH 7.3.

   

3-Hydroxy-7-O-methylcoclaurine

3-Hydroxy-7-O-methylcoclaurine

C18H21NO4 (315.1471)


   

6-O-Methyllaudanosoline

6-O-Methyllaudanosoline

C18H21NO4 (315.1471)


   

(Z)-(4-Hydroxycinnamoyl)-epilupinine

(Z)-(4-Hydroxycinnamoyl)-epilupinine

C19H25NO3 (315.1834)


   

Lupinyl trans-p-coumarate

(-)-(trans-4-Hydroxycinnamoyl)lupinine

C19H25NO3 (315.1834)


   
   

1-(3,4-Dimethoxyphenyl)-N-((2-methoxyphenyl)methyl)propan-2-amine

1-(3,4-Dimethoxyphenyl)-N-((2-methoxyphenyl)methyl)propan-2-amine

C19H25NO3 (315.1834)


   
   

3,4,5-trimethoxy-N-(1-phenylethyl)benzamide

3,4,5-trimethoxy-N-(1-phenylethyl)benzamide

C18H21NO4 (315.1471)


   

1-benzhydryl-3-phenoxyazetidine

1-benzhydryl-3-phenoxyazetidine

C22H21NO (315.1623)


   

CHEMBL355194

CHEMBL355194

C20H19N4+ (315.161)


   

5-[(E)-3-hydroxybut-1-enyl]-4-[4-[(E)-3-oxobut-1-enyl]anilino]oxolan-2-one

5-[(E)-3-hydroxybut-1-enyl]-4-[4-[(E)-3-oxobut-1-enyl]anilino]oxolan-2-one

C18H21NO4 (315.1471)


   

3,14-Dihydroangustine

3,14-Dihydroangustine

C20H17N3O (315.1372)


   
   

SCHEMBL1478023

SCHEMBL1478023

C19H25NO3 (315.1834)


   

Me ether- Dihydroerysodine

Me ether- Dihydroerysodine

C19H25NO3 (315.1834)


   
   

8,14-Dihydro-norsalutaridin

8,14-Dihydro-norsalutaridin

C18H21NO4 (315.1471)


   
   

17-demethylsinomenine|N-demethyl-sinomenine|N-demethylsinomenine

17-demethylsinomenine|N-demethyl-sinomenine|N-demethylsinomenine

C18H21NO4 (315.1471)


   
   

4-(3-methoxy-4-hydroxyphenyl)-4-<2-(acetylmethylamino)ethyl>cyclohexadienone

4-(3-methoxy-4-hydroxyphenyl)-4-<2-(acetylmethylamino)ethyl>cyclohexadienone

C18H21NO4 (315.1471)


   

(7Z,10S,12Z,13aS)-7,13-epoxy-2,3,9,10,11,13a-hexahydro-5,6-dimethoxy-1H-cyclodec[ij]isoquinolin-10-ol|stephalonganine A

(7Z,10S,12Z,13aS)-7,13-epoxy-2,3,9,10,11,13a-hexahydro-5,6-dimethoxy-1H-cyclodec[ij]isoquinolin-10-ol|stephalonganine A

C18H21NO4 (315.1471)


   

(-)-(trans-4-Hydroxycinnamoyl)lupinine

(-)-(trans-4-Hydroxycinnamoyl)lupinine

C19H25NO3 (315.1834)


   

2-O-acetylchlidanthine

2-O-acetylchlidanthine

C18H21NO4 (315.1471)


   
   

4-[2-(Acetylmethylamino)ethyl]-4-(4-hydroxy-3-methoxyphenyl)-2,4-cyclohexadien-1-one

4-[2-(Acetylmethylamino)ethyl]-4-(4-hydroxy-3-methoxyphenyl)-2,4-cyclohexadien-1-one

C18H21NO4 (315.1471)


   

trans-3-isobutyl-4-[4-(3-methyl-3-butenyloxy)phenyl]pyrrolidine-2,5-dione

trans-3-isobutyl-4-[4-(3-methyl-3-butenyloxy)phenyl]pyrrolidine-2,5-dione

C19H25NO3 (315.1834)


   

1-Methoxy-2-hydroxy-schelhammericine

1-Methoxy-2-hydroxy-schelhammericine

C19H25NO3 (315.1834)


   

parazoanthine B

parazoanthine B

C15H17N5O3 (315.1331)


   

11Beta-hydroxy-saxitoxin|11Beta-OH-STX|M2

11Beta-hydroxy-saxitoxin|11Beta-OH-STX|M2

C10H17N7O5 (315.1291)


   

2,3-dihydroxy-2-(1-hydroxyethyl)-3-methylbutanoic acid (2,3,5,7a-tetrahydro-1-hydroxy-1H-pyrrolizin-7-yl)methyl ester|leptanthine

2,3-dihydroxy-2-(1-hydroxyethyl)-3-methylbutanoic acid (2,3,5,7a-tetrahydro-1-hydroxy-1H-pyrrolizin-7-yl)methyl ester|leptanthine

C15H25NO6 (315.1682)


   
   

11beta-hydroxyerysodine

11beta-hydroxyerysodine

C18H21NO4 (315.1471)


   

10-Epimartensine A|Martensine A

10-Epimartensine A|Martensine A

C18H25N3O2 (315.1947)


   

(14E)-solanapyrone O

(14E)-solanapyrone O

C19H25NO3 (315.1834)


   
   

solanapyrone L

solanapyrone L

C19H25NO3 (315.1834)


   

N-de(phenylethyl)isohericerin

N-de(phenylethyl)isohericerin

C19H25NO3 (315.1834)


   
   
   

(R)-3-(2-hydroxy-3-methoxy-3-methylbutyl)-5-(3-methyl-1-oxo-2-butenyl)indole

(R)-3-(2-hydroxy-3-methoxy-3-methylbutyl)-5-(3-methyl-1-oxo-2-butenyl)indole

C19H25NO3 (315.1834)


   

11-O-methylcrinamine

11-O-methylcrinamine

C18H21NO4 (315.1471)


   
   

Morphinan-6,14-diol, 7,8-didehydro-4,5-epoxy-3-methoxy-17-methyl-, (5.alpha.,6.alpha.)-

Morphinan-6,14-diol, 7,8-didehydro-4,5-epoxy-3-methoxy-17-methyl-, (5.alpha.,6.alpha.)-

C18H21NO4 (315.1471)


   
   

SCHEMBL17713946

SCHEMBL17713946

C18H21NO4 (315.1471)


   

1-[(2E)-1-oxo-7-(3,4-methylenedioxy)phenylheptenyl]piperidine|piperine S

1-[(2E)-1-oxo-7-(3,4-methylenedioxy)phenylheptenyl]piperidine|piperine S

C19H25NO3 (315.1834)


   

Isocryprochine|isocryprocine

Isocryprochine|isocryprocine

C19H25NO3 (315.1834)


   

Dopamine 3-O-glucoside

Dopamine 3-O-glucoside

C14H21NO7 (315.1318)


   

Isolucidinine

Isolucidinine

C19H25NO3 (315.1834)


   
   

(-)-indolactam I|(-)-indolactam-Ile|Indolactam I

(-)-indolactam I|(-)-indolactam-Ile|Indolactam I

C18H25N3O2 (315.1947)


   
   

4-methoxy-1-methyl-3-(2S-acetoxy-3-ene-butyl)-2-quinolone

4-methoxy-1-methyl-3-(2S-acetoxy-3-ene-butyl)-2-quinolone

C18H21NO4 (315.1471)


   

16-hydroxy-3beta,15-dimethoxy-erythrin-1(6)-en-2-one|Erysotinon|erysotinone

16-hydroxy-3beta,15-dimethoxy-erythrin-1(6)-en-2-one|Erysotinon|erysotinone

C18H21NO4 (315.1471)


   
   
   
   
   
   
   
   
   
   
   
   

NCI60_000712

Butanoic acid,3-dihydroxy-2-(1-methylethyl)- (2,3,5,7a-tetrahydro-1-hydroxy-1H-pyrrolizin-7-yl) methyl ester, N-oxide, (1R-(1.alpha.,7(2R*,3S*),7a.beta))-

C15H25NO6 (315.1682)


Indicine N-oxide is a natural product found in Tournefortia argentea with data available. Indicine-N-Oxide is a natural pyrrolizidine alkaloid with antineoplastic properties. Indicine-N-oxide alkylates and crosslinks DNA. (NCI04)

   

Rinderine N-oxide

[(7S,8R)-7-hydroxy-4-oxido-5,6,7,8-tetrahydro-3H-pyrrolizin-4-ium-1-yl]methyl (2S)-2-hydroxy-2-[(1R)-1-hydroxyethyl]-3-methylbutanoate

C15H25NO6 (315.1682)


   

Echinatine oxide

Butanoic acid, 2,3-dihydroxy-2-(1-methylethyl)- (2,3,5,7a-tetrahydro-1-hydroxy-1H-pyrrolizin-7-yl) methyl ester, N-oxide, (1R-(1.alpha.,7(2R*,3S*),7a.b.eta.))-

C15H25NO6 (315.1682)


   

Lycopsamine N-oxide

Butanoic acid, 2,3-dihydroxy-2-(1-methylethyl)-, (2,3,5,7a-tetrahydro-1-hydroxy-1H-pyrrolizin-7-yl)methyl ester, N-oxide, [1R-[1?,7(2S*,3R*),7a?]]-; Butanoic acid, 2,3-dihydroxy-2-(1-methylethyl)-, (2,3,5,7a-tetrahydro-1-hydroxy-4-oxido-1H-pyrrolizin-7-yl)methyl ester, [1R-[1?,7(2S*,3R*),7a?]]-; Intermedine N-oxide

C15H25NO6 (315.1682)


Lycopsamine N-oxide is a natural product found in Symphytum officinale, Neatostema apulum, and Idea leuconoe with data available.

   

oxycodone

oxycodone

C18H21NO4 (315.1471)


D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D009294 - Narcotics D002492 - Central Nervous System Depressants > D009294 - Narcotics > D053610 - Opiate Alkaloids N - Nervous system > N02 - Analgesics > N02A - Opioids > N02AA - Natural opium alkaloids D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist D002491 - Central Nervous System Agents > D000700 - Analgesics CONFIDENCE standard compound; INTERNAL_ID 1602 IPB_RECORD: 1423; CONFIDENCE confident structure

   

Safranin

Safranin

[C20H19N4]+ (315.161)


Acquisition and generation of the data is financially supported by the Max-Planck-Society IPB_RECORD: 2561; CONFIDENCE confident structure

   

Safranine

3,7-Diamino-2,8-dimethyl-5-phenylphenazin-5-ium

[C20H19N4]+ (315.161)


Acquisition and generation of the data is financially supported in part by CREST/JST.

   

Saxagliptin (BMS-477118,Onglyza)

"Saxagliptin (BMS-477118,Onglyza)"

C18H25N3O2 (315.1947)


   

2,3-Dimethoxy-15-methyl-4b,5,6,9,8a,10-hexahydro-16-oxa-8a-aza-cyclopenta[a]phenanthren-17-one

"NCGC00160299-01!2,3-Dimethoxy-15-methyl-4b,5,6,9,8a,10-hexahydro-16-oxa-8a-aza-cyclopenta[a]phenanthren-17-one"

C18H21NO4 (315.1471)


   

Codeine N-Oxide

(3R,4R,4aR,7S,7aR,12bS)-9-methoxy-3-methyl-3-oxido-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-3-ium-7-ol

C18H21NO4 (315.1471)


   

C17H21N3O3_10b-Hydroxy-3-isobutyl-6,10b,11,11a-tetrahydro-2H-pyrazino[1,2:1,5]pyrrolo[2,3-b]indole-1,4(3H,5aH)-dione

NCGC00380254-01_C17H21N3O3_10b-Hydroxy-3-isobutyl-6,10b,11,11a-tetrahydro-2H-pyrazino[1,2:1,5]pyrrolo[2,3-b]indole-1,4(3H,5aH)-dione

C17H21N3O3 (315.1583)


   
   

N-methylcoclaurine N-oxide

N-methylcoclaurine N-oxide

[C18H21NO4]- (315.1471)


   

Intermedine N-oxide

Intermedine N-oxide

C15H25NO6 (315.1682)


CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 2272

   

Lycopsamine N-oxide

Lycopsamine N-oxide

C15H25NO6 (315.1682)


CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 2294

   

Nonyltyrazolone

Nonyltyrazolone

C19H25NO3 (315.1834)


   
   
   
   
   

Dehydroxyoxitropium

Dehydroxyoxitropium

C19H25NO3 (315.1834)


   
   
   
   

Pentazocine trans acid

Pentazocine trans acid

C19H25NO3 (315.1834)


   
   
   
   
   
   
   
   
   
   
   

3-O-Methyldobutamine

3-O-Methyldobutamine

C19H25NO3 (315.1834)


   

Mitiglinide

2-benzyl-4-(octahydro-1H-isoindol-2-yl)-4-oxobutanoic acid

C19H25NO3 (315.1834)


C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent > C98079 - Meglitinide Antidiabetic Agent A - Alimentary tract and metabolism > A10 - Drugs used in diabetes > A10B - Blood glucose lowering drugs, excl. insulins D007004 - Hypoglycemic Agents

   

Rotigotine

6-{propyl[2-(thiophen-2-yl)ethyl]amino}-5,6,7,8-tetrahydronaphthalen-1-ol

C19H25NOS (315.1657)


N - Nervous system > N04 - Anti-parkinson drugs > N04B - Dopaminergic agents > N04BC - Dopamine agonists D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018491 - Dopamine Agonists C78272 - Agent Affecting Nervous System > C66884 - Dopamine Agonist Rotigotine is a potent dopamine receptor agonist with Ki values of 0.71?nM, 4-15?nM, and 83?nM for the dopamine D3 receptor and D2, D5, D4 receptors and dopamine D1 receptor. Rotigotine a partial agonist of the 5-HT1A receptor, and an antagonist of the α2B-adrenergic receptor. Rotigotine can be used for parkinson's disease (PD) research[1][2][3][4].

   

saxagliptin

(1S,3S,5S)-2-[(2S)-2-amino-2-[(1r,3R,5R,7S)-3-hydroxyadamantan-1-yl]acetyl]-2-azabicyclo[3.1.0]hexane-3-carbonitrile

C18H25N3O2 (315.1947)


A - Alimentary tract and metabolism > A10 - Drugs used in diabetes > A10B - Blood glucose lowering drugs, excl. insulins > A10BH - Dipeptidyl peptidase 4 (dpp-4) inhibitors C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent > C98086 - Dipeptidyl Peptidase-4 Inhibitor D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D054795 - Incretins D007004 - Hypoglycemic Agents > D054873 - Dipeptidyl-Peptidase IV Inhibitors D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors C471 - Enzyme Inhibitor > C783 - Protease Inhibitor

   

Erythratine

19-methoxy-5,7-dioxa-13-azapentacyclo[11.7.0.0^{1,16}.0^{2,10}.0^{4,8}]icosa-2,4(8),9,16-tetraen-18-ol

C18H21NO4 (315.1471)


   

(E)-Piperolein A

(6E)-7-(2H-1,3-benzodioxol-5-yl)-1-(piperidin-1-yl)hept-6-en-1-one

C19H25NO3 (315.1834)


   

n-dihydroferuloyltyramine

3-(4-hydroxy-3-methoxyphenyl)-N-[2-(4-hydroxyphenyl)ethyl]propanamide

C18H21NO4 (315.1471)


   

N'-Hydroxysaxitoxin

N'-Hydroxysaxitoxin

C10H17N7O5 (315.1291)


   

Codeigene

14-hydroxy-10-methoxy-4-methyl-12-oxa-4$l^{5}-azapentacyclo[9.6.1.0^{1,13}.0^{5,17}.0^{7,18}]octadeca-7(18),8,10,15-tetraen-4-one

C18H21NO4 (315.1471)


   

(±)-Pandamarine

3-methyl-6-{4-[(2E)-4-methyl-5-oxo-2,5-dihydro-1H-pyrrol-2-ylidene]butyl}-1,6-diazaspiro[4.5]dec-3-en-2-one

C18H25N3O2 (315.1947)


   

1,3,5-Triazine,hexahydro-1,3,5-triphenyl-

1,3,5-Triazine,hexahydro-1,3,5-triphenyl-

C21H21N3 (315.1735)


   

2,6-bis(phenylmethoxy)benzonitrile

2,6-bis(phenylmethoxy)benzonitrile

C21H17NO2 (315.1259)


   

[4-(4-fluoro-phenyl)-piperazin-1-yl]-pyridin-4-yl-acetic acid

[4-(4-fluoro-phenyl)-piperazin-1-yl]-pyridin-4-yl-acetic acid

C17H18FN3O2 (315.1383)


   

1-BENZYL-2-(2-(1-METHYL-1H-PYRROL-2-YL)ETHYL)-1H-BENZO[D]IMIDAZOLE

1-BENZYL-2-(2-(1-METHYL-1H-PYRROL-2-YL)ETHYL)-1H-BENZO[D]IMIDAZOLE

C21H21N3 (315.1735)


   

2-ethylhexyl dihydrogen phosphate,2-(2-hydroxyethylamino)ethanol

2-ethylhexyl dihydrogen phosphate,2-(2-hydroxyethylamino)ethanol

C12H30NO6P (315.1811)


   

(R)-3-[((tert-Butoxy)carbonyl)amino]-4-(2,5-difluorophenyl)butanoic acid

(R)-3-[((tert-Butoxy)carbonyl)amino]-4-(2,5-difluorophenyl)butanoic acid

C15H19F2NO4 (315.1282)


   

1-(3,3-diphenylpropyl)piperidinium chloride

1-(3,3-diphenylpropyl)piperidinium chloride

C20H26ClN (315.1754)


   

[4-(4-fluoro-phenyl)-piperazin-1-yl]-pyridin-3-yl-acetic acid

[4-(4-fluoro-phenyl)-piperazin-1-yl]-pyridin-3-yl-acetic acid

C17H18FN3O2 (315.1383)


   

Dopamantine

Dopamantinum [INN-Latin]

C19H25NO3 (315.1834)


C78272 - Agent Affecting Nervous System > C38149 - Antiparkinsonian Agent

   

N-BOC-AMINO-(1,4-DIOXA-SPIRO[4.5]DEC-8-YL)-ACETICACID

N-BOC-AMINO-(1,4-DIOXA-SPIRO[4.5]DEC-8-YL)-ACETICACID

C15H25NO6 (315.1682)


   

DIETHYL 2-(1-(TERT-BUTOXYCARBONYL)AZETIDIN-3-YL)MALONATE

DIETHYL 2-(1-(TERT-BUTOXYCARBONYL)AZETIDIN-3-YL)MALONATE

C15H25NO6 (315.1682)


   

Boc-L-aspartic acid 4-cyclohexyl ester

Boc-L-aspartic acid 4-cyclohexyl ester

C15H25NO6 (315.1682)


   

diphenyl-[(3S)-1,2,3,4-tetrahydroisoquinolin-3-yl]methanol

diphenyl-[(3S)-1,2,3,4-tetrahydroisoquinolin-3-yl]methanol

C22H21NO (315.1623)


   

N-(3-chlorophenyl)-2-[4-(2-methylpropyl)phenyl]propanamide

N-(3-chlorophenyl)-2-[4-(2-methylpropyl)phenyl]propanamide

C19H22ClNO (315.139)


   

N-(2-chlorophenyl)-2-[4-(2-methylpropyl)phenyl]propanamide

N-(2-chlorophenyl)-2-[4-(2-methylpropyl)phenyl]propanamide

C19H22ClNO (315.139)


   

5,6,7,8-TETRAHYDRO-6-(PHENYLMETHYL)-4H-THIENO[2,3-D]AZEPINE-2-CARBOXYLIC ACID, ETHYL ESTER

5,6,7,8-TETRAHYDRO-6-(PHENYLMETHYL)-4H-THIENO[2,3-D]AZEPINE-2-CARBOXYLIC ACID, ETHYL ESTER

C18H21NO2S (315.1293)


   

4-(DIMETHYLAMINO)BENZALDEHYDE DIPHENYLHYDRAZONE

4-(DIMETHYLAMINO)BENZALDEHYDE DIPHENYLHYDRAZONE

C21H21N3 (315.1735)


   

Dihydroethidium

Dihydroethidium

C21H21N3 (315.1735)


   

Boc-(S)-3-Amino-3-(1-naphthyl)-propionic acid

Boc-(S)-3-Amino-3-(1-naphthyl)-propionic acid

C18H21NO4 (315.1471)


   

(R)-N-Boc-1-Naphthylalanine

(R)-N-Boc-1-Naphthylalanine

C18H21NO4 (315.1471)


   

6-[propyl(2-thiophen-3-ylethyl)amino]-5,6,7,8-tetrahydronaphthalen-1-ol

6-[propyl(2-thiophen-3-ylethyl)amino]-5,6,7,8-tetrahydronaphthalen-1-ol

C19H25NOS (315.1657)


   

Boc-(R)-3-Amino-3-(1-naphthyl)-propionic acid

Boc-(R)-3-Amino-3-(1-naphthyl)-propionic acid

C18H21NO4 (315.1471)


   

2-(BIPHENYL-3-YL)-N-PHENETHYLACETAMIDE

2-(BIPHENYL-3-YL)-N-PHENETHYLACETAMIDE

C22H21NO (315.1623)


   

METHYL (2R)-2-[(TERT-BUTOXYCARBONYL)AMINO]-3-(2,5-DIFLUOROPHENYL)PROPANOATE

METHYL (2R)-2-[(TERT-BUTOXYCARBONYL)AMINO]-3-(2,5-DIFLUOROPHENYL)PROPANOATE

C15H19F2NO4 (315.1282)


   

(3R)-3-[(tert-Butoxycarbonyl)amino]-4-(2,4-difluorophenyl)butanoic acid

(3R)-3-[(tert-Butoxycarbonyl)amino]-4-(2,4-difluorophenyl)butanoic acid

C15H19F2NO4 (315.1282)


   

3-((tert-butoxycarbonyl)amino)-4-(2,5-difluorophenyl)butanoic acid

3-((tert-butoxycarbonyl)amino)-4-(2,5-difluorophenyl)butanoic acid

C15H19F2NO4 (315.1282)


   

BOC-(R)-3-AMINO-4-(3,4-DIFLUORO-PHENYL)-BUTYRIC ACID

BOC-(R)-3-AMINO-4-(3,4-DIFLUORO-PHENYL)-BUTYRIC ACID

C15H19F2NO4 (315.1282)


   

2-Oxazolidinone,4,5,5-triphenyl-

2-Oxazolidinone,4,5,5-triphenyl-

C21H17NO2 (315.1259)


   

N-(4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PHENYL)METHANESULFONAMIDE

N-(4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PHENYL)METHANESULFONAMIDE

C13H22BNO5S (315.1312)


   
   

Fmoc-Ala-OH (2,3,3,3-D4)

Fmoc-Ala-OH (2,3,3,3-D4)

C18H13D4NO4 (315.1409)


   

Benzyl 2-Fluoro-4-Morpholinobenzoate

Benzyl 2-Fluoro-4-Morpholinobenzoate

C18H18FNO3 (315.1271)


   

TERT-BUTYL 3-(2,2-DIMETHYL-4,6-DIOXO-1,3-DIOXAN-5-YL)-3-OXOPROPYLCARBAMATE

TERT-BUTYL 3-(2,2-DIMETHYL-4,6-DIOXO-1,3-DIOXAN-5-YL)-3-OXOPROPYLCARBAMATE

C14H21NO7 (315.1318)


   

1-Benzhydryl-3-phenoxy-azetidine

1-Benzhydryl-3-phenoxy-azetidine

C22H21NO (315.1623)


   

Boc-D-Asp(OcHex)-OH

Boc-D-Asp(OcHex)-OH

C15H25NO6 (315.1682)


   

(S)-N-Boc-1-Naphthylalanine

(S)-N-Boc-1-Naphthylalanine

C18H21NO4 (315.1471)


   

Boc-3-(2-naphthyl)-D-alanine

Boc-3-(2-naphthyl)-D-alanine

C18H21NO4 (315.1471)


   

Boc-3-(2-Naphthyl)-L-alanine

Boc-3-(2-Naphthyl)-L-alanine

C18H21NO4 (315.1471)


   

tert-butyl 3-(quinoxalin-2-yloxy)pyrrolidine-1-carboxylate

tert-butyl 3-(quinoxalin-2-yloxy)pyrrolidine-1-carboxylate

C17H21N3O3 (315.1583)


   

dibutyl hydrogen phosphate, compound with 2,2-iminodiethanol (1:1)

dibutyl hydrogen phosphate, compound with 2,2-iminodiethanol (1:1)

C12H30NO6P (315.1811)


   

Methanone, (3,5-dimethyl-4-isoxazolyl)[4-(3-methoxyphenyl)-1-piperazinyl]-

Methanone, (3,5-dimethyl-4-isoxazolyl)[4-(3-methoxyphenyl)-1-piperazinyl]-

C17H21N3O3 (315.1583)


   

(Z)-2-Methoxy-5-(3,4,5-Trimethoxystyryl)Aniline

(Z)-2-Methoxy-5-(3,4,5-Trimethoxystyryl)Aniline

C18H21NO4 (315.1471)


   

TERT-BUTYL 3-OXO-2-PHENYL-2,3,4,5-TETRAHYDRO-1H-PYRAZOLO[3,4-C]PYRIDINE-6(7H)-CARBOXYLATE

TERT-BUTYL 3-OXO-2-PHENYL-2,3,4,5-TETRAHYDRO-1H-PYRAZOLO[3,4-C]PYRIDINE-6(7H)-CARBOXYLATE

C17H21N3O3 (315.1583)


   

1-benzhydryl-3-phenylazetidin-3-ol

1-benzhydryl-3-phenylazetidin-3-ol

C22H21NO (315.1623)


   

h-val-tyr-nh2 hcl

h-val-tyr-nh2 hcl

C14H22ClN3O3 (315.135)


   

TERT-BUTYL 5-(4-METHYLPIPERAZIN-1-YL)-1H-INDOLE-1-CARBOXYLATE

TERT-BUTYL 5-(4-METHYLPIPERAZIN-1-YL)-1H-INDOLE-1-CARBOXYLATE

C18H25N3O2 (315.1947)


   

metoclopramide N-oxide

metoclopramide N-oxide

C14H22ClN3O3 (315.135)


   

Moxisylyte hydrochloride

Moxisylyte hydrochloride

C16H26ClNO3 (315.1601)


C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013565 - Sympatholytics D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D008916 - Miotics D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents Moxisylyte (hydrochloride) is (alpha 1-blocker) antagonist, it can vasodilates cerebral vessels without reducing blood pressure. It is also used locally in the eye to reverse the mydriasis caused by phenylephrine and other sympathomimetic agents. [1][2]

   

(R)-4,5,5-TRIPHENYLOXAZOLIDIN-2-ONE

(R)-4,5,5-TRIPHENYLOXAZOLIDIN-2-ONE

C21H17NO2 (315.1259)


   
   

4-Dibenzylamino-2-methylbenzo-aldehyde

4-Dibenzylamino-2-methylbenzo-aldehyde

C22H21NO (315.1623)


   

Morphinan-6,10-diol,7,8-didehydro-4,5-epoxy-3-methoxy-17-methyl-, (5a,6a)-

Morphinan-6,10-diol,7,8-didehydro-4,5-epoxy-3-methoxy-17-methyl-, (5a,6a)-

C18H21NO4 (315.1471)


   

Ethyl 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole-2-carboxylate

Ethyl 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole-2-carboxylate

C17H22BNO4 (315.1642)


   

(S)-3-((tert-butoxycarbonyl)amino)-3-(naphthalen-2-yl)propanoic acid

(S)-3-((tert-butoxycarbonyl)amino)-3-(naphthalen-2-yl)propanoic acid

C18H21NO4 (315.1471)


   

(R)-Boc-3-(2-naphthyl)-β-Ala-OH

(R)-Boc-3-(2-naphthyl)-β-Ala-OH

C18H21NO4 (315.1471)


   

2-((tert-butoxycarbonyl)amino)-3-(naphthalen-1-yl)propanoic acid

2-((tert-butoxycarbonyl)amino)-3-(naphthalen-1-yl)propanoic acid

C18H21NO4 (315.1471)


   

DIETHYL 1,5-DIMETHYL-3-PHENYL-1H-PYRROLE-2,4-DICARBOXYLATE

DIETHYL 1,5-DIMETHYL-3-PHENYL-1H-PYRROLE-2,4-DICARBOXYLATE

C18H21NO4 (315.1471)


   

(4R,4aS,7S,7aR,12bS)-9-methoxy-3-methyl-1,2,4,7,7a,13-hexahydro-4,12-methanobenzofuro[3,2-e]isoquinoline-4a,7-diol

(4R,4aS,7S,7aR,12bS)-9-methoxy-3-methyl-1,2,4,7,7a,13-hexahydro-4,12-methanobenzofuro[3,2-e]isoquinoline-4a,7-diol

C18H21NO4 (315.1471)


   
   

N-(4-chlorophenyl)-2-[4-(2-methylpropyl)phenyl]propanamide

N-(4-chlorophenyl)-2-[4-(2-methylpropyl)phenyl]propanamide

C19H22ClNO (315.139)


   

Doxepin hydrochloride

(E)-doxepin hydrochloride

C19H22ClNO (315.139)


D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D006993 - Hypnotics and Sedatives C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent > C94727 - Tricyclic Antidepressant D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists D000890 - Anti-Infective Agents > D000935 - Antifungal Agents Doxepin hydrochloride is an orally active tricyclic antidepressant agent. Doxepin hydrochloride is a potent and selective histamine receptor H1 antagonist. Doxepin hydrochloride is also a potent CYP450 inhibitor and significantly inhibits CYP450 2C19 and 1A2[1][2]. Doxepin inhibits reuptake of serotonin and norepinephrine as a tricyclic antidepressant[3].
. Doxepin has therapeutic effects in atopic dermatitis,chronic urticarial,can improve cognitive processes, protect central nervous system[4].
. Doxepin has also been proposed as a protective factor against oxidative stress[5].
.

   

(S)-3-(1-Boc-2-piperazinylmethyl)indole

(S)-3-(1-Boc-2-piperazinylmethyl)indole

C18H25N3O2 (315.1947)


   

Boc-(S)-3-amino-4-(3,4-difluoro-phenyl)-butyric acid

Boc-(S)-3-amino-4-(3,4-difluoro-phenyl)-butyric acid

C15H19F2NO4 (315.1282)


   

H-Asp(Obzl)-OtBu.HCl

H-Asp(Obzl)-OtBu.HCl

C15H22ClNO4 (315.1237)


   

(R,R)-OCTAHYDRO-BENZOIMIDAZOLE-2-THIONE

(R,R)-OCTAHYDRO-BENZOIMIDAZOLE-2-THIONE

C18H21NO4 (315.1471)


   

Boc-(R,S)-3-amino-3-(2-naphthyl)-proponic acid

Boc-(R,S)-3-amino-3-(2-naphthyl)-proponic acid

C18H21NO4 (315.1471)


   

4-[(4-methoxybenzylidene)amino]azobenzene

4-[(4-methoxybenzylidene)amino]azobenzene

C20H17N3O (315.1372)


   

6-chloro-N-cyclopentyl-5-(4-ethylphenyl)-2-methylpyrimidin-4-amine

6-chloro-N-cyclopentyl-5-(4-ethylphenyl)-2-methylpyrimidin-4-amine

C18H22ClN3 (315.1502)


   

N-(3-TriethylamMoniumpropyl)-4-Methylpyridinium dibromide

N-(3-TriethylamMoniumpropyl)-4-Methylpyridinium dibromide

C15H28BrN2+ (315.1436)


   

1-(9,10-DIHYDROANTHRACEN-9-YL)-3-(DIMETHYLAMINO)PROPAN-1-ONE HYDROCHLORIDE

1-(9,10-DIHYDROANTHRACEN-9-YL)-3-(DIMETHYLAMINO)PROPAN-1-ONE HYDROCHLORIDE

C19H22ClNO (315.139)


   

(2E)-2-(1,3-BENZOTHIAZOL-2-YL)-3-[4-(DIMETHYLAMINO)PHENYL]ACRYLONITRILE

(2E)-2-(1,3-BENZOTHIAZOL-2-YL)-3-[4-(DIMETHYLAMINO)PHENYL]ACRYLONITRILE

C22H21NO (315.1623)


   

Benzenamine,N-[(4-methoxyphenyl)methylene]-4-(2-phenyldiazenyl)-

Benzenamine,N-[(4-methoxyphenyl)methylene]-4-(2-phenyldiazenyl)-

C20H17N3O (315.1372)


   

R-Mitiglinide Calcium

R-Mitiglinide Calcium

C19H25NO3 (315.1834)


   

(1R,3R,5R)-2-[(2R)-2-Amino-2-(3-hydroxyadamantan-1-yl)acetyl]-2-azabicyclo[3.1.0]hexane-3-carbonitrile

(1R,3R,5R)-2-[(2R)-2-Amino-2-(3-hydroxyadamantan-1-yl)acetyl]-2-azabicyclo[3.1.0]hexane-3-carbonitrile

C18H25N3O2 (315.1947)


   

Saxagliptin (S,R,S,S)-Isomer

Saxagliptin (S,R,S,S)-Isomer

C18H25N3O2 (315.1947)


   

Saxagliptin (R,S,R,S)-Isomer

Saxagliptin (R,S,R,S)-Isomer

C18H25N3O2 (315.1947)


   

Trofinetide

Trofinetide

C13H21N3O6 (315.143)


C78272 - Agent Affecting Nervous System Trofinetide (NNZ-2566), a synthetic analogue of the endogenous N-terminus tripeptide, Glycine-Proline-Glutamate (GPE), has been shown to be neuroprotective in animal models of brain injury.

   

8-CHLORO-6,11-DIHYDRO-11-(4-PIPERIDINYLIDENE)-5H-BENZO[5,6]CYCLOHEPTA[1,2-B]PYRIDINE-D5

8-CHLORO-6,11-DIHYDRO-11-(4-PIPERIDINYLIDENE)-5H-BENZO[5,6]CYCLOHEPTA[1,2-B]PYRIDINE-D5

C19H14ClD5N2 (315.1551)


   

3-Fluoro-4-propyl-[1,1:4,1-terphenyl]-4-carbonitrile

3-Fluoro-4-propyl-[1,1:4,1-terphenyl]-4-carbonitrile

C22H18FN (315.1423)


   

3-METHOXY-4-[3-(1-PYRROLIDINYL)PROPOXY]-BENZOIC ACID HYDROCHLORIDE

3-METHOXY-4-[3-(1-PYRROLIDINYL)PROPOXY]-BENZOIC ACID HYDROCHLORIDE

C15H22ClNO4 (315.1237)


   

2-(3-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)propyl)isoindoline-1,3-dione

2-(3-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)propyl)isoindoline-1,3-dione

C17H22BNO4 (315.1642)


   

5-Amino-1-Boc-3,4,5,6-tetrahydro-2H-[2,4]bipyridinyl hydrochloride

5-Amino-1-Boc-3,4,5,6-tetrahydro-2H-[2,4]bipyridinyl hydrochloride

C15H26ClN3O2 (315.1713)


   

(R)-5-(2-(2,5-difluorophenyl)pyrrolidin-1-yl)pyrazolo[1,5-a]pyrimidin-3-amine

(R)-5-(2-(2,5-difluorophenyl)pyrrolidin-1-yl)pyrazolo[1,5-a]pyrimidin-3-amine

C16H15F2N5 (315.1295)


   

Tert-Butyl 5-Methyl-3-Oxo-2,3-Dihydrospiro[Indene-1,4-Piperidine]-1-Carboxylate

Tert-Butyl 5-Methyl-3-Oxo-2,3-Dihydrospiro[Indene-1,4-Piperidine]-1-Carboxylate

C19H25NO3 (315.1834)


   

1-(1-Ethoxycarbonyl-4-piperidinyl)-4-phenyl-4-imidazolin-2-one

1-(1-Ethoxycarbonyl-4-piperidinyl)-4-phenyl-4-imidazolin-2-one

C17H21N3O3 (315.1583)


   

TERT-BUTYL 4-OXO-3,4-DIHYDRO-2H-SPIRO[NAPHTHALENE-1,4-PIPERIDINE]-1-CARBOXYLATE

TERT-BUTYL 4-OXO-3,4-DIHYDRO-2H-SPIRO[NAPHTHALENE-1,4-PIPERIDINE]-1-CARBOXYLATE

C19H25NO3 (315.1834)


   

benzyl 4-(3-methoxy-3-oxopropyl)-3,5-dimethyl-1H-pyrrole-2-carboxylate

benzyl 4-(3-methoxy-3-oxopropyl)-3,5-dimethyl-1H-pyrrole-2-carboxylate

C18H21NO4 (315.1471)


   

N-Acetylglutaminylglutamine amide

N-Acetylglutaminylglutamine amide

C12H21N5O5 (315.1543)


   

4H-Cyclopenta[a][1,3]dioxolo[4,5-h]pyrrolo[2,1-b][3]benzazepin-1-ol, 1,5,6,8,9,14b-hexahydro-2-methoxy-

4H-Cyclopenta[a][1,3]dioxolo[4,5-h]pyrrolo[2,1-b][3]benzazepin-1-ol, 1,5,6,8,9,14b-hexahydro-2-methoxy-

C18H21NO4 (315.1471)


   
   

1-(4-Methyl-1-piperidinyl)-2-[(3-methyl-2-quinoxalinyl)thio]ethanone

1-(4-Methyl-1-piperidinyl)-2-[(3-methyl-2-quinoxalinyl)thio]ethanone

C17H21N3OS (315.1405)


   

Talibegron

Talibegron

C18H21NO4 (315.1471)


C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist

   

3H-Pyrazolo[3,4-b]pyridin-3-one, 2,7-dihydro-4,6-dimethyl-2,7-diphenyl-

3H-Pyrazolo[3,4-b]pyridin-3-one, 2,7-dihydro-4,6-dimethyl-2,7-diphenyl-

C20H17N3O (315.1372)


   

L-Leucine, L-seryl-L-prolyl-

L-Leucine, L-seryl-L-prolyl-

C14H25N3O5 (315.1794)


   

4,4-[(4-Iminocyclohexa-2,5-dien-1-ylidene)methylene]bis(2-methylaniline)

4,4-[(4-Iminocyclohexa-2,5-dien-1-ylidene)methylene]bis(2-methylaniline)

C21H21N3 (315.1735)


   

Percodan

Percodan

C18H21NO4 (315.1471)


D000893 - Anti-Inflammatory Agents > D000894 - Anti-Inflammatory Agents, Non-Steroidal > D012459 - Salicylates D002492 - Central Nervous System Depressants > D009294 - Narcotics > D053610 - Opiate Alkaloids

   

2-Butoxy-N-[2-(dimethylamino)ethyl]quinoline-4-carboxamide

2-Butoxy-N-[2-(dimethylamino)ethyl]quinoline-4-carboxamide

C18H25N3O2 (315.1947)


   

C19-gibberellin skeleton

C19-gibberellin skeleton

C19H23O4- (315.1596)


   

N-acetyl-L-glutaminyl-L-glutamine

N-acetyl-L-glutaminyl-L-glutamine

C12H19N4O6- (315.1305)


   

(2S)-2-[[(2S)-2-aminopentanoyl]amino]-3-[[(E)-4-methoxy-4-oxobut-2-enoyl]amino]propanoic acid

(2S)-2-[[(2S)-2-aminopentanoyl]amino]-3-[[(E)-4-methoxy-4-oxobut-2-enoyl]amino]propanoic acid

C13H21N3O6 (315.143)


   

3-[[(E)-4-Methoxy-4-oxo-2-butenoyl]amino]-L-Ala-L-Val-OH

3-[[(E)-4-Methoxy-4-oxo-2-butenoyl]amino]-L-Ala-L-Val-OH

C13H21N3O6 (315.143)


   

(+)-Norprotosinomenine

(+)-Norprotosinomenine

C18H21NO4 (315.1471)


   

(1R)-1-[(4-hydroxy-3-methoxyphenyl)methyl]-6-methoxy-1,2,3,4-tetrahydroisoquinolin-7-ol

(1R)-1-[(4-hydroxy-3-methoxyphenyl)methyl]-6-methoxy-1,2,3,4-tetrahydroisoquinolin-7-ol

C18H21NO4 (315.1471)


   
   

FMDP-L-valine

FMDP-L-valine

C13H21N3O6 (315.143)


   

Oct-4-enedioylcarnitine

Oct-4-enedioylcarnitine

C15H25NO6 (315.1682)


   

Oct-5-enedioylcarnitine

Oct-5-enedioylcarnitine

C15H25NO6 (315.1682)


   

(6Z)-Oct-6-enedioylcarnitine

(6Z)-Oct-6-enedioylcarnitine

C15H25NO6 (315.1682)


   

(2E)-Oct-2-enedioylcarnitine

(2E)-Oct-2-enedioylcarnitine

C15H25NO6 (315.1682)


   

(4aR,4bR,7R,9aR,10S,10aR)-1-methyl-8-methylene-13-oxododecahydro-4a,1-(epoxymethano)-7,9a-methanobenzo[a]azulene-10-carboxylate

(4aR,4bR,7R,9aR,10S,10aR)-1-methyl-8-methylene-13-oxododecahydro-4a,1-(epoxymethano)-7,9a-methanobenzo[a]azulene-10-carboxylate

C19H23O4- (315.1596)


   

Aculene A

Aculene A

C19H25NO3 (315.1834)


A carboxylic ester resulting from the formal condensation of the hydroxy group of aculene C with the carboxylic acid group of L-proline. It is a sesquiterpenoid isolated from the fungus Aspergillus aculeatus.

   

N-(2-ethoxyphenyl)-2-(4-methoxyphenoxy)propanamide

N-(2-ethoxyphenyl)-2-(4-methoxyphenoxy)propanamide

C18H21NO4 (315.1471)


   

2-oxo-1,4-dihydroquinazoline-3-carboxylic acid [(1R,5S)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl] ester

2-oxo-1,4-dihydroquinazoline-3-carboxylic acid [(1R,5S)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl] ester

C17H21N3O3 (315.1583)


   

N-(3,7-dimethyl-2,6-octadienylidene)-2-nitrobenzohydrazide

N-(3,7-dimethyl-2,6-octadienylidene)-2-nitrobenzohydrazide

C17H21N3O3 (315.1583)


   

6-(3-furanyl)-N-[(3-methylphenyl)methyl]-4-quinazolinamine

6-(3-furanyl)-N-[(3-methylphenyl)methyl]-4-quinazolinamine

C20H17N3O (315.1372)


   

(12S)-4,5-Dimethoxy-12-methyl-13-oxa-10-azatetracyclo[8.7.0.02,7.011,15]heptadeca-2,4,6,11(15)-tetraen-14-one

(12S)-4,5-Dimethoxy-12-methyl-13-oxa-10-azatetracyclo[8.7.0.02,7.011,15]heptadeca-2,4,6,11(15)-tetraen-14-one

C18H21NO4 (315.1471)


   
   

Pyranonigrin E

Pyranonigrin E

C18H21NO4 (315.1471)


A member of the class of pyranopyrroles with formula C18H21NO4, originally isolated from Aspergillus niger.

   

N-benzyl-2,2-diphenylpropanamide

N-benzyl-2,2-diphenylpropanamide

C22H21NO (315.1623)


   
   

Val-FMDP

Val-FMDP

C13H21N3O6 (315.143)


A dipeptide composed of 3-{[(2E)-4-methoxy-4-oxobut-2-enoyl]amino}alanine and L-valine joined by peptide linkages.

   

6-Amino-2-methyl-8-phenyl-1,6,8,8a-tetrahydroisoquinoline-5,7,7-tricarbonitrile

6-Amino-2-methyl-8-phenyl-1,6,8,8a-tetrahydroisoquinoline-5,7,7-tricarbonitrile

C19H17N5 (315.1484)


   

4-Methyl-6-[2-(4-methyl-1-piperidinyl)-2-oxoethoxy]-1-benzopyran-2-one

4-Methyl-6-[2-(4-methyl-1-piperidinyl)-2-oxoethoxy]-1-benzopyran-2-one

C18H21NO4 (315.1471)


   

1,3-Dimethyl-5-[1-(1-phenylethylamino)propylidene]-1,3-diazinane-2,4,6-trione

1,3-Dimethyl-5-[1-(1-phenylethylamino)propylidene]-1,3-diazinane-2,4,6-trione

C17H21N3O3 (315.1583)


   

N-(4-fluorophenyl)-6-methyl-1-propyl-3,4-dihydro-1H-pyrrolo[1,2-a]pyrazine-2-carboxamide

N-(4-fluorophenyl)-6-methyl-1-propyl-3,4-dihydro-1H-pyrrolo[1,2-a]pyrazine-2-carboxamide

C18H22FN3O (315.1747)


   

(4Z)-5-methyl-4-[(1-methylindol-3-yl)methylidene]-2-phenylpyrazol-3-one

(4Z)-5-methyl-4-[(1-methylindol-3-yl)methylidene]-2-phenylpyrazol-3-one

C20H17N3O (315.1372)


   

N-(3,7-dimethyl-2,6-octadien-1-ylidene)-4-nitrobenzohydrazide

N-(3,7-dimethyl-2,6-octadien-1-ylidene)-4-nitrobenzohydrazide

C17H21N3O3 (315.1583)


   

N-cycloheptyl-3-(5,7-dioxo-6-pyrrolo[3,4-b]pyridinyl)propanamide

N-cycloheptyl-3-(5,7-dioxo-6-pyrrolo[3,4-b]pyridinyl)propanamide

C17H21N3O3 (315.1583)


   

(1R,5S)-6-[[5-(2-fluoro-4-methoxyphenyl)-1H-pyrazol-4-yl]methyl]-6-azabicyclo[3.2.1]octane

(1R,5S)-6-[[5-(2-fluoro-4-methoxyphenyl)-1H-pyrazol-4-yl]methyl]-6-azabicyclo[3.2.1]octane

C18H22FN3O (315.1747)


   
   

(5-Methyl-1,2-oxazol-3-yl)-[4-(5-propylpyrimidin-2-yl)piperazin-1-yl]methanone

(5-Methyl-1,2-oxazol-3-yl)-[4-(5-propylpyrimidin-2-yl)piperazin-1-yl]methanone

C16H21N5O2 (315.1695)


   

[(E)-1-[5-(3-methylbutoxymethyl)-2-oxooxolan-3-yl]propan-2-ylideneamino]thiourea

[(E)-1-[5-(3-methylbutoxymethyl)-2-oxooxolan-3-yl]propan-2-ylideneamino]thiourea

C14H25N3O3S (315.1617)


   

3-O-Acetyl-8-O-demethylmaritidine

3-O-Acetyl-8-O-demethylmaritidine

C18H21NO4 (315.1471)


   
   
   
   
   
   
   
   
   

(1-Methyl-3-imidazo[1,2-a]pyridin-4-iumyl)-diphenylmethanol

(1-Methyl-3-imidazo[1,2-a]pyridin-4-iumyl)-diphenylmethanol

C21H19N2O+ (315.1497)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

(2E)-7-carboxyhept-2-enoylcarnitine

(2E)-7-carboxyhept-2-enoylcarnitine

C15H25NO6 (315.1682)


An O-acylcarnitine having (2E)-7-carboxyhept-2-enoyl as the acyl substituent.

   
   

Huprine 19 dication

Huprine 19 dication

C18H22ClN3+2 (315.1502)


   
   

(2E)-10-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]dec-2-enoate

(2E)-10-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]dec-2-enoate

C16H27O6- (315.1808)


   

(2S)-2-amino-N-[(E)-(6-methyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl)methylidene]-3-phenylpropanehydrazide (non-preferred name)

(2S)-2-amino-N-[(E)-(6-methyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl)methylidene]-3-phenylpropanehydrazide (non-preferred name)

C15H17N5O3 (315.1331)


   

(E,9R)-9-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxydec-2-enoate

(E,9R)-9-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxydec-2-enoate

C16H27O6- (315.1808)


   

(1S)-1-(3-Hydroxy-4-methoxybenzyl)-2-methyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline

(1S)-1-(3-Hydroxy-4-methoxybenzyl)-2-methyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline

C18H21NO4 (315.1471)


   

Saxagliptin (BMS-477118,Onglyza)

Saxagliptin (BMS-477118,Onglyza)

C18H25N3O2 (315.1947)


A - Alimentary tract and metabolism > A10 - Drugs used in diabetes > A10B - Blood glucose lowering drugs, excl. insulins > A10BH - Dipeptidyl peptidase 4 (dpp-4) inhibitors D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D054795 - Incretins D007004 - Hypoglycemic Agents > D054873 - Dipeptidyl-Peptidase IV Inhibitors D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors

   

2-Ethoxy-N-(2-(diethylamino)ethyl)-4-quinolinecarboxamide

2-Ethoxy-N-(2-(diethylamino)ethyl)-4-quinolinecarboxamide

C18H25N3O2 (315.1947)


   

2-Butoxy-N-(2-(ethylamino)ethyl)-4-quinolinecarboxamide

2-Butoxy-N-(2-(ethylamino)ethyl)-4-quinolinecarboxamide

C18H25N3O2 (315.1947)


   

N-methylcoclaurine N-oxide

N-methylcoclaurine N-oxide

C18H21NO4 (315.1471)


   

N-Acetyl-alanyl-valyl-alanine methyl ester

N-Acetyl-alanyl-valyl-alanine methyl ester

C14H25N3O5 (315.1794)


   

N-Acetyl-alanyl-leucyl-glycine methylester

N-Acetyl-alanyl-leucyl-glycine methylester

C14H25N3O5 (315.1794)


   

N-Acetyl-glycyl-leucyl-alanine methylester

N-Acetyl-glycyl-leucyl-alanine methylester

C14H25N3O5 (315.1794)


   

2-Ethoxycarbonyl-3-ethyl-4-methyl-5-benzyloxycarbonyl-pyrrole

2-Ethoxycarbonyl-3-ethyl-4-methyl-5-benzyloxycarbonyl-pyrrole

C18H21NO4 (315.1471)


   

2,4-Diisopropyl-4,4A-dihydro-1H-(1,3,5)triazino(1,2-A)quinoline-1,3,6(2H,5H)-trione

2,4-Diisopropyl-4,4A-dihydro-1H-(1,3,5)triazino(1,2-A)quinoline-1,3,6(2H,5H)-trione

C17H21N3O3 (315.1583)


   

Unii-6yrl8bwd9H

Unii-6yrl8bwd9H

C10H17N7O5 (315.1291)


   

(R)-Norreticuline

(R)-Norreticuline

C18H21NO4 (315.1471)


   

Neosaxitoxin

Neosaxitoxin

C10H17N7O5 (315.1291)


A pyrrolopurine that is saxitoxin carrying a hydroxy substituent on the nitrogen atom at position 5. It is a sodium channel blocker that is undergoing clinical trials as a prolonged-duration local anesthetic.

   

(±)-Rotigotine

1-Naphthalenol, 5,6,7,8-tetrahydro-6-[propyl[2-(2-thienyl)ethyl]amino]-

C19H25NOS (315.1657)


D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018491 - Dopamine Agonists

   
   

N-Hydroxysaxitoxin

N-Hydroxysaxitoxin

C10H17N7O5 (315.1291)


   

3,7-Diamino-2,8-dimethyl-5-phenylphenazin-5-ium

3,7-Diamino-2,8-dimethyl-5-phenylphenazin-5-ium

C20H19N4+ (315.161)


   

oscr#15(1-)

oscr#15(1-)

C16H27O6 (315.1808)


A hydroxy fatty acid ascaroside anion that is the conjugate base of oscr#15, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

ascr#15(1-)

ascr#15(1-)

C16H27O6 (315.1808)


Conjugate base of ascr#15

   

O-octenedioylcarnitine

O-octenedioylcarnitine

C15H25NO6 (315.1682)


An O-acylcarnitine obtained by formal condensation of one of the carboxy groups of any octenedioic acid with the hydroxy group of carnitine.

   

gibberellin A9(1-)

gibberellin A9(1-)

C19H23O4 (315.1596)


A gibberellin carboxylic acid anion that is the conjugate base of gibberellin A9, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

(R,S)-Norreticuline

(R,S)-Norreticuline

C18H21NO4 (315.1471)


   
   
   

2'-O-MOE-5-Me-rC

2'-O-MOE-5-Me-rC

C13H21N3O6 (315.143)


2'-O-MOE-5-Me-rC is an active compound. 2'-O-MOE-5-Me-rC can be used for oligonucleotide synthesis[1].

   

A-804598

A-804598

C19H17N5 (315.1484)


A-804598 is a CNS penetrant, competitive and selective P2X7 receptor antagonist with IC50s of 9 nM, 10 nM and 11 nM for mouse, rat and human P2X7 receptors, respectively[1].

   

NG-497

NG-497

C18H21NO4 (315.1471)


NG-497 is a selective human adipose triglyceride lipase (ATGL) inhibitor that targets the enzymatically active patatin-like domain of human ATGL. NG-497 has potential value for tumor research[1].

   

(3as,4r,10as)-6-amino-10,10-dihydroxy-4-[(c-hydroxycarbonimidoyloxy)methyl]-2-imino-1h,3h,3ah,4h,8h,9h-pyrrolo[1,2-c]purin-5-ium-5-olate

(3as,4r,10as)-6-amino-10,10-dihydroxy-4-[(c-hydroxycarbonimidoyloxy)methyl]-2-imino-1h,3h,3ah,4h,8h,9h-pyrrolo[1,2-c]purin-5-ium-5-olate

C10H17N7O5 (315.1291)


   

7,8-dimethoxy-2h,4h,5h,10h,11h-indolo[7a,1-a]isoquinoline-5,11-diol

7,8-dimethoxy-2h,4h,5h,10h,11h-indolo[7a,1-a]isoquinoline-5,11-diol

C18H21NO4 (315.1471)


   

(1s,15r,16s)-5-hydroxy-4-methoxy-9-azatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-2(7),3,5,12-tetraen-15-yl acetate

(1s,15r,16s)-5-hydroxy-4-methoxy-9-azatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-2(7),3,5,12-tetraen-15-yl acetate

C18H21NO4 (315.1471)


   

1-{14-hydroxy-9-methoxy-11-oxa-4-azatetracyclo[8.6.1.0¹,¹².0⁶,¹⁷]heptadeca-6,8,10(17),15-tetraen-4-yl}ethanone

1-{14-hydroxy-9-methoxy-11-oxa-4-azatetracyclo[8.6.1.0¹,¹².0⁶,¹⁷]heptadeca-6,8,10(17),15-tetraen-4-yl}ethanone

C18H21NO4 (315.1471)


   

(2s,3s,10r,12s)-12-methoxy-4-methyl-11,16,18-trioxa-4-azapentacyclo[11.7.0.0²,¹⁰.0³,⁷.0¹⁵,¹⁹]icosa-1(20),7,13,15(19)-tetraene

(2s,3s,10r,12s)-12-methoxy-4-methyl-11,16,18-trioxa-4-azapentacyclo[11.7.0.0²,¹⁰.0³,⁷.0¹⁵,¹⁹]icosa-1(20),7,13,15(19)-tetraene

C18H21NO4 (315.1471)


   

15,18-dimethoxy-5,7-dioxa-12-azapentacyclo[10.5.2.0¹,¹³.0²,¹⁰.0⁴,⁸]nonadeca-2,4(8),9,16-tetraene

15,18-dimethoxy-5,7-dioxa-12-azapentacyclo[10.5.2.0¹,¹³.0²,¹⁰.0⁴,⁸]nonadeca-2,4(8),9,16-tetraene

C18H21NO4 (315.1471)


   

(1s,13s,15r)-9,15-dimethoxy-5,7-dioxa-12-azapentacyclo[10.5.2.0¹,¹³.0²,¹⁰.0⁴,⁸]nonadeca-2,4(8),9,16-tetraene

(1s,13s,15r)-9,15-dimethoxy-5,7-dioxa-12-azapentacyclo[10.5.2.0¹,¹³.0²,¹⁰.0⁴,⁸]nonadeca-2,4(8),9,16-tetraene

C18H21NO4 (315.1471)


   

1-[3-(2-hydroxy-3-methoxy-3-methylbutyl)-1h-indol-5-yl]-3-methylbut-2-en-1-one

1-[3-(2-hydroxy-3-methoxy-3-methylbutyl)-1h-indol-5-yl]-3-methylbut-2-en-1-one

C19H25NO3 (315.1834)


   

(1s,4's,6r)-6-hydroxy-10',11'-dimethoxy-5'-azaspiro[cyclohexane-1,2'-tricyclo[6.3.1.0⁴,¹²]dodecane]-1'(11'),2,8'(12'),9'-tetraen-4-one

(1s,4's,6r)-6-hydroxy-10',11'-dimethoxy-5'-azaspiro[cyclohexane-1,2'-tricyclo[6.3.1.0⁴,¹²]dodecane]-1'(11'),2,8'(12'),9'-tetraen-4-one

C18H21NO4 (315.1471)


   

12-methoxy-4-methyl-11,16,18-trioxa-4-azapentacyclo[11.7.0.0²,¹⁰.0³,⁷.0¹⁵,¹⁹]icosa-1(20),7,13,15(19)-tetraene

12-methoxy-4-methyl-11,16,18-trioxa-4-azapentacyclo[11.7.0.0²,¹⁰.0³,⁷.0¹⁵,¹⁹]icosa-1(20),7,13,15(19)-tetraene

C18H21NO4 (315.1471)


   

(1s,14r,17r)-5,17-dimethoxy-11-azatetracyclo[9.7.0.0¹,¹⁴.0²,⁷]octadeca-2(7),3,5,15-tetraen-4-ol

(1s,14r,17r)-5,17-dimethoxy-11-azatetracyclo[9.7.0.0¹,¹⁴.0²,⁷]octadeca-2(7),3,5,15-tetraen-4-ol

C19H25NO3 (315.1834)


   

(1s,18r,19r)-19-methoxy-5,7-dioxa-13-azapentacyclo[11.7.0.0¹,¹⁶.0²,¹⁰.0⁴,⁸]icosa-2,4(8),9,16-tetraen-18-ol

(1s,18r,19r)-19-methoxy-5,7-dioxa-13-azapentacyclo[11.7.0.0¹,¹⁶.0²,¹⁰.0⁴,⁸]icosa-2,4(8),9,16-tetraen-18-ol

C18H21NO4 (315.1471)


   

(9bs,11r)-7-hydroxy-8,11-dimethoxy-1h,2h,4h,5h,10h,11h-indolo[7a,1-a]isoquinolin-12-one

(9bs,11r)-7-hydroxy-8,11-dimethoxy-1h,2h,4h,5h,10h,11h-indolo[7a,1-a]isoquinolin-12-one

C18H21NO4 (315.1471)


   

n-{2-[1-(4-hydroxy-3-methoxyphenyl)-4-oxocyclohexa-2,5-dien-1-yl]ethyl}-n-methylacetamide

n-{2-[1-(4-hydroxy-3-methoxyphenyl)-4-oxocyclohexa-2,5-dien-1-yl]ethyl}-n-methylacetamide

C18H21NO4 (315.1471)


   

(10s,13s)-10-[(2s)-butan-2-yl]-13-(hydroxymethyl)-9-methyl-3,9,12-triazatricyclo[6.6.1.0⁴,¹⁵]pentadeca-1,4,6,8(15),11-pentaen-11-ol

(10s,13s)-10-[(2s)-butan-2-yl]-13-(hydroxymethyl)-9-methyl-3,9,12-triazatricyclo[6.6.1.0⁴,¹⁵]pentadeca-1,4,6,8(15),11-pentaen-11-ol

C18H25N3O2 (315.1947)


   

(1r,7ar)-1-hydroxy-7-({[(2r)-2-hydroxy-2-[(1s)-1-hydroxyethyl]-3-methylbutanoyl]oxy}methyl)-2,3,5,7a-tetrahydro-1h-pyrrolizin-4-ium-4-olate

(1r,7ar)-1-hydroxy-7-({[(2r)-2-hydroxy-2-[(1s)-1-hydroxyethyl]-3-methylbutanoyl]oxy}methyl)-2,3,5,7a-tetrahydro-1h-pyrrolizin-4-ium-4-olate

C15H25NO6 (315.1682)


   

(1s,13r,16s,18s)-18-methoxy-15-methyl-5,7,12-trioxa-15-azapentacyclo[11.7.0.0¹,¹⁶.0²,¹⁰.0⁴,⁸]icosa-2,4(8),9,19-tetraene

(1s,13r,16s,18s)-18-methoxy-15-methyl-5,7,12-trioxa-15-azapentacyclo[11.7.0.0¹,¹⁶.0²,¹⁰.0⁴,⁸]icosa-2,4(8),9,19-tetraene

C18H21NO4 (315.1471)


   

(-)-norreticuline

(-)-norreticuline

C18H21NO4 (315.1471)


   

octahydro-1h-quinolizin-1-ylmethyl 3-(4-hydroxyphenyl)prop-2-enoate

octahydro-1h-quinolizin-1-ylmethyl 3-(4-hydroxyphenyl)prop-2-enoate

C19H25NO3 (315.1834)


   

15,16-dimethoxy-18-oxa-10-azatetracyclo[7.7.1.1²,⁸.0¹³,¹⁷]octadeca-1(16),2,7,13(17),14-pentaen-5-ol

15,16-dimethoxy-18-oxa-10-azatetracyclo[7.7.1.1²,⁸.0¹³,¹⁷]octadeca-1(16),2,7,13(17),14-pentaen-5-ol

C18H21NO4 (315.1471)


   

7-(2h-1,3-benzodioxol-5-yl)-1-(piperidin-1-yl)hept-2-en-1-one

7-(2h-1,3-benzodioxol-5-yl)-1-(piperidin-1-yl)hept-2-en-1-one

C19H25NO3 (315.1834)


   

2-[(5s,7s,7as)-5-(acetyloxy)-1-methyl-2,3,5,6,7,7a-hexahydroindol-7-yl]benzoic acid

2-[(5s,7s,7as)-5-(acetyloxy)-1-methyl-2,3,5,6,7,7a-hexahydroindol-7-yl]benzoic acid

C18H21NO4 (315.1471)


   

(2s,3r,6r)-4-methoxy-16,18-dioxa-10-azapentacyclo[11.7.0.0²,⁶.0⁶,¹⁰.0¹⁵,¹⁹]icosa-1(20),4,13,15(19)-tetraen-3-ol

(2s,3r,6r)-4-methoxy-16,18-dioxa-10-azapentacyclo[11.7.0.0²,⁶.0⁶,¹⁰.0¹⁵,¹⁹]icosa-1(20),4,13,15(19)-tetraen-3-ol

C18H21NO4 (315.1471)


   

9,15-dimethoxy-5,7-dioxa-12-azapentacyclo[10.5.2.0¹,¹³.0²,¹⁰.0⁴,⁸]nonadeca-2,4(8),9,16-tetraene

9,15-dimethoxy-5,7-dioxa-12-azapentacyclo[10.5.2.0¹,¹³.0²,¹⁰.0⁴,⁸]nonadeca-2,4(8),9,16-tetraene

C18H21NO4 (315.1471)


   

3-o-acetylsanguinine

NA

C18H21NO4 (315.1471)


{"Ingredient_id": "HBIN009043","Ingredient_name": "3-o-acetylsanguinine","Alias": "NA","Ingredient_formula": "C18H21NO4","Ingredient_Smile": "CC(=O)OC1CC2C3(CCN(CC4=C3C(=C(C=C4)O)O2)C)C=C1","Ingredient_weight": "315.4 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "506","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "11197829","DrugBank_id": "NA"}

   

amuroline

NA

C19H25NO3 (315.1834)


{"Ingredient_id": "HBIN015930","Ingredient_name": "amuroline","Alias": "NA","Ingredient_formula": "C19H25NO3","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "1100","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

(1s,17r)-4,17-dimethoxy-11-azatetracyclo[9.7.0.0¹,¹⁴.0²,⁷]octadeca-2(7),3,5,14-tetraen-5-ol

(1s,17r)-4,17-dimethoxy-11-azatetracyclo[9.7.0.0¹,¹⁴.0²,⁷]octadeca-2(7),3,5,14-tetraen-5-ol

C19H25NO3 (315.1834)


   

5-[3-(4-hydroxy-4-methylpent-2-en-1-yl)-3-methyloxiran-2-yl]-3-methyl-1-(1h-pyrrol-2-yl)penta-2,4-dien-1-one

5-[3-(4-hydroxy-4-methylpent-2-en-1-yl)-3-methyloxiran-2-yl]-3-methyl-1-(1h-pyrrol-2-yl)penta-2,4-dien-1-one

C19H25NO3 (315.1834)


   

5,17-dimethoxy-11-azatetracyclo[9.7.0.0¹,¹⁴.0²,⁷]octadeca-2(7),3,5,14-tetraen-4-ol

5,17-dimethoxy-11-azatetracyclo[9.7.0.0¹,¹⁴.0²,⁷]octadeca-2(7),3,5,14-tetraen-4-ol

C19H25NO3 (315.1834)


   

7-hydroxy-8,11-dimethoxy-1h,2h,4h,5h,10h,11h-indolo[7a,1-a]isoquinolin-12-one

7-hydroxy-8,11-dimethoxy-1h,2h,4h,5h,10h,11h-indolo[7a,1-a]isoquinolin-12-one

C18H21NO4 (315.1471)


   

1-[(14s)-14-hydroxy-9-methoxy-11-oxa-4-azatetracyclo[8.6.1.0¹,¹².0⁶,¹⁷]heptadeca-6,8,10(17),15-tetraen-4-yl]ethanone

1-[(14s)-14-hydroxy-9-methoxy-11-oxa-4-azatetracyclo[8.6.1.0¹,¹².0⁶,¹⁷]heptadeca-6,8,10(17),15-tetraen-4-yl]ethanone

C18H21NO4 (315.1471)


   

(8r)-4,8-dimethoxy-8-(3-methylbut-2-en-1-yl)-5h,6h-furo[2,3-b]quinolin-7-one

(8r)-4,8-dimethoxy-8-(3-methylbut-2-en-1-yl)-5h,6h-furo[2,3-b]quinolin-7-one

C18H21NO4 (315.1471)


   

5,7-dioxa-14-azapentacyclo[12.7.0.0¹,¹⁷.0²,¹⁰.0⁴,⁸]henicosa-2,4(8),9,17-tetraene-19,20-diol

5,7-dioxa-14-azapentacyclo[12.7.0.0¹,¹⁷.0²,¹⁰.0⁴,⁸]henicosa-2,4(8),9,17-tetraene-19,20-diol

C18H21NO4 (315.1471)


   

1-[(3-hydroxy-4-methoxyphenyl)methyl]-7-methoxy-1,2,3,4-tetrahydroisoquinolin-6-ol

1-[(3-hydroxy-4-methoxyphenyl)methyl]-7-methoxy-1,2,3,4-tetrahydroisoquinolin-6-ol

C18H21NO4 (315.1471)


   

(1s,7ar)-1-hydroxy-7-({[(2s)-2-hydroxy-2-[(1s)-1-hydroxyethyl]-3-methylbutanoyl]oxy}methyl)-2,3,5,7a-tetrahydro-1h-pyrrolizin-4-ium-4-olate

(1s,7ar)-1-hydroxy-7-({[(2s)-2-hydroxy-2-[(1s)-1-hydroxyethyl]-3-methylbutanoyl]oxy}methyl)-2,3,5,7a-tetrahydro-1h-pyrrolizin-4-ium-4-olate

C15H25NO6 (315.1682)


   

n-[2-(3,4,5-trimethoxyphenyl)ethyl]benzenecarboximidic acid

n-[2-(3,4,5-trimethoxyphenyl)ethyl]benzenecarboximidic acid

C18H21NO4 (315.1471)


   

3-{[(2s)-2-amino-1-hydroxy-3-methylbutylidene]amino}-2-hydroxy-3-{7-oxo-4-oxa-1-azabicyclo[3.2.0]heptan-3-yl}propanoic acid

3-{[(2s)-2-amino-1-hydroxy-3-methylbutylidene]amino}-2-hydroxy-3-{7-oxo-4-oxa-1-azabicyclo[3.2.0]heptan-3-yl}propanoic acid

C13H21N3O6 (315.143)


   

(2r,3s,6r)-4-methoxy-16,18-dioxa-10-azapentacyclo[11.7.0.0²,⁶.0⁶,¹⁰.0¹⁵,¹⁹]icosa-1(20),4,13,15(19)-tetraen-3-ol

(2r,3s,6r)-4-methoxy-16,18-dioxa-10-azapentacyclo[11.7.0.0²,⁶.0⁶,¹⁰.0¹⁵,¹⁹]icosa-1(20),4,13,15(19)-tetraen-3-ol

C18H21NO4 (315.1471)


   

13-(hydroxymethyl)-9-methyl-10-(sec-butyl)-3,9,12-triazatricyclo[6.6.1.0⁴,¹⁵]pentadeca-1,4,6,8(15),11-pentaen-11-ol

13-(hydroxymethyl)-9-methyl-10-(sec-butyl)-3,9,12-triazatricyclo[6.6.1.0⁴,¹⁵]pentadeca-1,4,6,8(15),11-pentaen-11-ol

C18H25N3O2 (315.1947)


   

(5s,9bs,11r)-8,11-dimethoxy-2h,4h,5h,10h,11h-indolo[7a,1-a]isoquinoline-5,7-diol

(5s,9bs,11r)-8,11-dimethoxy-2h,4h,5h,10h,11h-indolo[7a,1-a]isoquinoline-5,7-diol

C18H21NO4 (315.1471)


   

(2r,3r,6r)-4-methoxy-16,18-dioxa-10-azapentacyclo[11.7.0.0²,⁶.0⁶,¹⁰.0¹⁵,¹⁹]icosa-1(20),4,13,15(19)-tetraen-3-ol

(2r,3r,6r)-4-methoxy-16,18-dioxa-10-azapentacyclo[11.7.0.0²,⁶.0⁶,¹⁰.0¹⁵,¹⁹]icosa-1(20),4,13,15(19)-tetraen-3-ol

C18H21NO4 (315.1471)


   

(2e,4z)-5-(6-methoxy-2h-1,3-benzodioxol-5-yl)-1-(piperidin-1-yl)penta-2,4-dien-1-one

(2e,4z)-5-(6-methoxy-2h-1,3-benzodioxol-5-yl)-1-(piperidin-1-yl)penta-2,4-dien-1-one

C18H21NO4 (315.1471)


   

(1r,2s,4'r)-10',11'-dimethoxy-5'-methyl-5'-azaspiro[cyclohexane-1,2'-tricyclo[6.3.1.0⁴,¹²]dodecane]-1'(11'),3,8'(12'),9'-tetraen-2-ol

(1r,2s,4'r)-10',11'-dimethoxy-5'-methyl-5'-azaspiro[cyclohexane-1,2'-tricyclo[6.3.1.0⁴,¹²]dodecane]-1'(11'),3,8'(12'),9'-tetraen-2-ol

C19H25NO3 (315.1834)


   

(5r,9bs,11r)-8,11-dimethoxy-2h,4h,5h,10h,11h-indolo[7a,1-a]isoquinoline-5,7-diol

(5r,9bs,11r)-8,11-dimethoxy-2h,4h,5h,10h,11h-indolo[7a,1-a]isoquinoline-5,7-diol

C18H21NO4 (315.1471)


   

5-(3,7-dimethylocta-2,6-dien-1-yl)-6-methoxy-3h-isoindole-1,4-diol

5-(3,7-dimethylocta-2,6-dien-1-yl)-6-methoxy-3h-isoindole-1,4-diol

C19H25NO3 (315.1834)


   

5,7,18-trioxa-14-azahexacyclo[12.8.0.0¹,¹⁷.0²,¹⁰.0⁴,⁸.0¹⁷,¹⁹]docosa-2,4(8),9-trien-21-ol

5,7,18-trioxa-14-azahexacyclo[12.8.0.0¹,¹⁷.0²,¹⁰.0⁴,⁸.0¹⁷,¹⁹]docosa-2,4(8),9-trien-21-ol

C18H21NO4 (315.1471)


   

10',11'-dimethoxy-5'-methyl-5'-azaspiro[cyclohexane-1,2'-tricyclo[6.3.1.0⁴,¹²]dodecane]-1'(11'),2,8'(12'),9'-tetraen-4-ol

10',11'-dimethoxy-5'-methyl-5'-azaspiro[cyclohexane-1,2'-tricyclo[6.3.1.0⁴,¹²]dodecane]-1'(11'),2,8'(12'),9'-tetraen-4-ol

C19H25NO3 (315.1834)


   

(1s,12s,14r)-9-hydroxy-4-methyl-11-oxa-4-azatetracyclo[8.6.1.0¹,¹².0⁶,¹⁷]heptadeca-6,8,10(17),15-tetraen-14-yl acetate

(1s,12s,14r)-9-hydroxy-4-methyl-11-oxa-4-azatetracyclo[8.6.1.0¹,¹².0⁶,¹⁷]heptadeca-6,8,10(17),15-tetraen-14-yl acetate

C18H21NO4 (315.1471)


   

(2s)-2-[(2-amino-1-hydroxy-3-{[(2e)-1-hydroxy-4-methoxy-4-oxobut-2-en-1-ylidene]amino}propylidene)amino]-3-methylbutanoic acid

(2s)-2-[(2-amino-1-hydroxy-3-{[(2e)-1-hydroxy-4-methoxy-4-oxobut-2-en-1-ylidene]amino}propylidene)amino]-3-methylbutanoic acid

C13H21N3O6 (315.143)


   

4,5-dimethoxy-16-methyl-9-oxa-16-azatetracyclo[8.7.0.0²,⁷.0¹³,¹⁷]heptadeca-2(7),3,5,12-tetraen-8-one

4,5-dimethoxy-16-methyl-9-oxa-16-azatetracyclo[8.7.0.0²,⁷.0¹³,¹⁷]heptadeca-2(7),3,5,12-tetraen-8-one

C18H21NO4 (315.1471)


   

5-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-6-methoxy-3h-isoindole-1,4-diol

5-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-6-methoxy-3h-isoindole-1,4-diol

C19H25NO3 (315.1834)


   

4-methoxy-3-methyl-5-[(4e)-3-methyl-5-oxa-10-azatricyclo[8.3.0.0²,⁶]trideca-1(13),11-dien-4-ylidene]furan-2-one

4-methoxy-3-methyl-5-[(4e)-3-methyl-5-oxa-10-azatricyclo[8.3.0.0²,⁶]trideca-1(13),11-dien-4-ylidene]furan-2-one

C18H21NO4 (315.1471)


   

3-hydroxy-6-methyl-7-methylidene-2-[(1e,3e)-nona-1,3-dien-1-yl]pyrano[2,3-c]pyrrole-4,5-dione

3-hydroxy-6-methyl-7-methylidene-2-[(1e,3e)-nona-1,3-dien-1-yl]pyrano[2,3-c]pyrrole-4,5-dione

C18H21NO4 (315.1471)


   

(8s)-4,8-dimethoxy-8-[(2r)-3-methylbutan-2-yl]furo[2,3-b]quinolin-7-one

(8s)-4,8-dimethoxy-8-[(2r)-3-methylbutan-2-yl]furo[2,3-b]quinolin-7-one

C18H21NO4 (315.1471)


   

(5r,8r)-15,16-dimethoxy-18-oxa-10-azatetracyclo[7.7.1.1²,⁸.0¹³,¹⁷]octadeca-1(16),2,9,13(17),14-pentaen-5-ol

(5r,8r)-15,16-dimethoxy-18-oxa-10-azatetracyclo[7.7.1.1²,⁸.0¹³,¹⁷]octadeca-1(16),2,9,13(17),14-pentaen-5-ol

C18H21NO4 (315.1471)


   
   

(1r,10s,12s)-5-hydroxy-4-methoxy-9-azatetracyclo[7.5.2.0¹,¹⁰.0²,⁷]hexadeca-2(7),3,5,13-tetraen-12-yl acetate

(1r,10s,12s)-5-hydroxy-4-methoxy-9-azatetracyclo[7.5.2.0¹,¹⁰.0²,⁷]hexadeca-2(7),3,5,13-tetraen-12-yl acetate

C18H21NO4 (315.1471)


   

(3ar,4s)-1-ethyl-3a,6-dimethyl-3-oxo-4,5-dihydroazulen-4-yl (2s)-pyrrolidine-2-carboxylate

(3ar,4s)-1-ethyl-3a,6-dimethyl-3-oxo-4,5-dihydroazulen-4-yl (2s)-pyrrolidine-2-carboxylate

C19H25NO3 (315.1834)


   

9-hydroxy-4-methyl-11-oxa-4-azatetracyclo[8.6.1.0¹,¹².0⁶,¹⁷]heptadeca-6,8,10(17),15-tetraen-14-yl acetate

9-hydroxy-4-methyl-11-oxa-4-azatetracyclo[8.6.1.0¹,¹².0⁶,¹⁷]heptadeca-6,8,10(17),15-tetraen-14-yl acetate

C18H21NO4 (315.1471)


   

(1s,4r,4's)-10',11'-dimethoxy-5'-methyl-5'-azaspiro[cyclohexane-1,2'-tricyclo[6.3.1.0⁴,¹²]dodecane]-1'(11'),2,8'(12'),9'-tetraen-4-ol

(1s,4r,4's)-10',11'-dimethoxy-5'-methyl-5'-azaspiro[cyclohexane-1,2'-tricyclo[6.3.1.0⁴,¹²]dodecane]-1'(11'),2,8'(12'),9'-tetraen-4-ol

C19H25NO3 (315.1834)


   

5-hydroxy-3-{4-[(3-methylbut-3-en-1-yl)oxy]phenyl}-4-(2-methylpropyl)-3,4-dihydropyrrol-2-one

5-hydroxy-3-{4-[(3-methylbut-3-en-1-yl)oxy]phenyl}-4-(2-methylpropyl)-3,4-dihydropyrrol-2-one

C19H25NO3 (315.1834)


   

5-(6-methoxy-2h-1,3-benzodioxol-5-yl)-1-(piperidin-1-yl)penta-2,4-dien-1-one

5-(6-methoxy-2h-1,3-benzodioxol-5-yl)-1-(piperidin-1-yl)penta-2,4-dien-1-one

C18H21NO4 (315.1471)


   

(2z,5r,8r)-15,16-dimethoxy-18-oxa-10-azatetracyclo[7.7.1.1²,⁸.0¹³,¹⁷]octadeca-1(16),2,9,13(17),14-pentaen-5-ol

(2z,5r,8r)-15,16-dimethoxy-18-oxa-10-azatetracyclo[7.7.1.1²,⁸.0¹³,¹⁷]octadeca-1(16),2,9,13(17),14-pentaen-5-ol

C18H21NO4 (315.1471)


   

15,16-dimethoxy-5,7-dioxa-12-azapentacyclo[10.6.1.0²,¹⁰.0⁴,⁸.0¹³,¹⁸]nonadeca-2,4(8),9,17-tetraene

15,16-dimethoxy-5,7-dioxa-12-azapentacyclo[10.6.1.0²,¹⁰.0⁴,⁸.0¹³,¹⁸]nonadeca-2,4(8),9,17-tetraene

C18H21NO4 (315.1471)


   

(1s,13s,15r,18r)-15,18-dimethoxy-5,7-dioxa-12-azapentacyclo[10.5.2.0¹,¹³.0²,¹⁰.0⁴,⁸]nonadeca-2,4(8),9,16-tetraene

(1s,13s,15r,18r)-15,18-dimethoxy-5,7-dioxa-12-azapentacyclo[10.5.2.0¹,¹³.0²,¹⁰.0⁴,⁸]nonadeca-2,4(8),9,16-tetraene

C18H21NO4 (315.1471)


   

[(3as,4r,9r,10as)-9,10,10-trihydroxy-2,6-diimino-hexahydro-1h-pyrrolo[1,2-c]purin-4-yl]methoxycarboximidic acid

[(3as,4r,9r,10as)-9,10,10-trihydroxy-2,6-diimino-hexahydro-1h-pyrrolo[1,2-c]purin-4-yl]methoxycarboximidic acid

C10H17N7O5 (315.1291)


   

3-hydroxy-4,12-dimethoxy-17-azatetracyclo[7.5.3.0¹,¹⁰.0²,⁷]heptadeca-2,4,6,11-tetraen-13-one

3-hydroxy-4,12-dimethoxy-17-azatetracyclo[7.5.3.0¹,¹⁰.0²,⁷]heptadeca-2,4,6,11-tetraen-13-one

C18H21NO4 (315.1471)


   

(5s,9bs,11r)-7,8-dimethoxy-2h,4h,5h,10h,11h-indolo[7a,1-a]isoquinoline-5,11-diol

(5s,9bs,11r)-7,8-dimethoxy-2h,4h,5h,10h,11h-indolo[7a,1-a]isoquinoline-5,11-diol

C18H21NO4 (315.1471)


   

[(3as,4r,10as)-5,10,10-trihydroxy-2,6-diimino-hexahydropyrrolo[1,2-c]purin-4-yl]methoxycarboximidic acid

[(3as,4r,10as)-5,10,10-trihydroxy-2,6-diimino-hexahydropyrrolo[1,2-c]purin-4-yl]methoxycarboximidic acid

C10H17N7O5 (315.1291)


   

(1s,13s,15s,16s)-15,16-dimethoxy-5,7-dioxa-12-azapentacyclo[10.6.1.0²,¹⁰.0⁴,⁸.0¹³,¹⁸]nonadeca-2,4(8),9,17-tetraene

(1s,13s,15s,16s)-15,16-dimethoxy-5,7-dioxa-12-azapentacyclo[10.6.1.0²,¹⁰.0⁴,⁸.0¹³,¹⁸]nonadeca-2,4(8),9,17-tetraene

C18H21NO4 (315.1471)


   

8,11-dimethoxy-2h,4h,5h,10h,11h-indolo[7a,1-a]isoquinoline-5,7-diol

8,11-dimethoxy-2h,4h,5h,10h,11h-indolo[7a,1-a]isoquinoline-5,7-diol

C18H21NO4 (315.1471)


   

4,17-dimethoxy-11-azatetracyclo[9.7.0.0¹,¹⁴.0²,⁷]octadeca-2(7),3,5,14-tetraen-5-ol

4,17-dimethoxy-11-azatetracyclo[9.7.0.0¹,¹⁴.0²,⁷]octadeca-2(7),3,5,14-tetraen-5-ol

C19H25NO3 (315.1834)


   

(1s,9ar)-octahydro-1h-quinolizin-1-ylmethyl (2z)-3-(4-hydroxyphenyl)prop-2-enoate

(1s,9ar)-octahydro-1h-quinolizin-1-ylmethyl (2z)-3-(4-hydroxyphenyl)prop-2-enoate

C19H25NO3 (315.1834)


   

4,8-dimethoxy-8-(3-methylbut-2-en-1-yl)-5h,6h-furo[2,3-b]quinolin-7-one

4,8-dimethoxy-8-(3-methylbut-2-en-1-yl)-5h,6h-furo[2,3-b]quinolin-7-one

C18H21NO4 (315.1471)


   

(2r,6r)-4-methoxy-16,18-dioxa-10-azapentacyclo[11.7.0.0²,⁶.0⁶,¹⁰.0¹⁵,¹⁹]icosa-1(20),4,13,15(19)-tetraen-3-ol

(2r,6r)-4-methoxy-16,18-dioxa-10-azapentacyclo[11.7.0.0²,⁶.0⁶,¹⁰.0¹⁵,¹⁹]icosa-1(20),4,13,15(19)-tetraen-3-ol

C18H21NO4 (315.1471)


   

(1r,17s,19r,21r)-5,7,18-trioxa-14-azahexacyclo[12.8.0.0¹,¹⁷.0²,¹⁰.0⁴,⁸.0¹⁷,¹⁹]docosa-2,4(8),9-trien-21-ol

(1r,17s,19r,21r)-5,7,18-trioxa-14-azahexacyclo[12.8.0.0¹,¹⁷.0²,¹⁰.0⁴,⁸.0¹⁷,¹⁹]docosa-2,4(8),9-trien-21-ol

C18H21NO4 (315.1471)


   

(1s,19s,20r)-5,7-dioxa-14-azapentacyclo[12.7.0.0¹,¹⁷.0²,¹⁰.0⁴,⁸]henicosa-2,4(8),9,17-tetraene-19,20-diol

(1s,19s,20r)-5,7-dioxa-14-azapentacyclo[12.7.0.0¹,¹⁷.0²,¹⁰.0⁴,⁸]henicosa-2,4(8),9,17-tetraene-19,20-diol

C18H21NO4 (315.1471)


   

(1r)-1-(3-carbamimidamidopropyl)-2h,3h,4h,9h-pyrido[3,4-b]indole-1-carboxylic acid

(1r)-1-(3-carbamimidamidopropyl)-2h,3h,4h,9h-pyrido[3,4-b]indole-1-carboxylic acid

C16H21N5O2 (315.1695)


   

n-[(2s)-2-(3,4-dimethoxyphenyl)-2-methoxyethyl]benzenecarboximidic acid

n-[(2s)-2-(3,4-dimethoxyphenyl)-2-methoxyethyl]benzenecarboximidic acid

C18H21NO4 (315.1471)


   

1-[(1r,12r,14s)-14-hydroxy-9-methoxy-11-oxa-4-azatetracyclo[8.6.1.0¹,¹².0⁶,¹⁷]heptadeca-6,8,10(17),15-tetraen-4-yl]ethanone

1-[(1r,12r,14s)-14-hydroxy-9-methoxy-11-oxa-4-azatetracyclo[8.6.1.0¹,¹².0⁶,¹⁷]heptadeca-6,8,10(17),15-tetraen-4-yl]ethanone

C18H21NO4 (315.1471)


   

1-{3-[(2r)-2-hydroxy-3-methoxy-3-methylbutyl]-1h-indol-5-yl}-3-methylbut-2-en-1-one

1-{3-[(2r)-2-hydroxy-3-methoxy-3-methylbutyl]-1h-indol-5-yl}-3-methylbut-2-en-1-one

C19H25NO3 (315.1834)


   

2,2-dimethyl-4,7-diphenyl-1,3-benzoxazol-6-one

2,2-dimethyl-4,7-diphenyl-1,3-benzoxazol-6-one

C21H17NO2 (315.1259)


   

(1r,9ar)-octahydro-1h-quinolizin-1-ylmethyl (2e)-3-(4-hydroxyphenyl)prop-2-enoate

(1r,9ar)-octahydro-1h-quinolizin-1-ylmethyl (2e)-3-(4-hydroxyphenyl)prop-2-enoate

C19H25NO3 (315.1834)


   

3-hydroxy-4-methoxy-9-methyl-9-azapentacyclo[8.8.0.0¹,⁶.0²,¹³.0¹³,¹⁸]octadeca-5,14-dien-16-one

3-hydroxy-4-methoxy-9-methyl-9-azapentacyclo[8.8.0.0¹,⁶.0²,¹³.0¹³,¹⁸]octadeca-5,14-dien-16-one

C19H25NO3 (315.1834)


   

(1s,14r,17r)-4,17-dimethoxy-11-azatetracyclo[9.7.0.0¹,¹⁴.0²,⁷]octadeca-2(7),3,5,15-tetraen-5-ol

(1s,14r,17r)-4,17-dimethoxy-11-azatetracyclo[9.7.0.0¹,¹⁴.0²,⁷]octadeca-2(7),3,5,15-tetraen-5-ol

C19H25NO3 (315.1834)


   

[(3as,4r,9s,10as)-9,10,10-trihydroxy-2,6-diimino-hexahydro-1h-pyrrolo[1,2-c]purin-4-yl]methoxycarboximidic acid

[(3as,4r,9s,10as)-9,10,10-trihydroxy-2,6-diimino-hexahydro-1h-pyrrolo[1,2-c]purin-4-yl]methoxycarboximidic acid

C10H17N7O5 (315.1291)


   

4-methoxy-3-methyl-5-[(2r,3s,4z,6r)-3-methyl-5-oxa-10-azatricyclo[8.3.0.0²,⁶]trideca-1(13),11-dien-4-ylidene]furan-2-one

4-methoxy-3-methyl-5-[(2r,3s,4z,6r)-3-methyl-5-oxa-10-azatricyclo[8.3.0.0²,⁶]trideca-1(13),11-dien-4-ylidene]furan-2-one

C18H21NO4 (315.1471)


   

1-ethyl-3a,6-dimethyl-3-oxo-4,5-dihydroazulen-4-yl pyrrolidine-2-carboxylate

1-ethyl-3a,6-dimethyl-3-oxo-4,5-dihydroazulen-4-yl pyrrolidine-2-carboxylate

C19H25NO3 (315.1834)


   

(1s,9as)-octahydro-1h-quinolizin-1-ylmethyl (2e)-3-(4-hydroxyphenyl)prop-2-enoate

(1s,9as)-octahydro-1h-quinolizin-1-ylmethyl (2e)-3-(4-hydroxyphenyl)prop-2-enoate

C19H25NO3 (315.1834)


   

3-hydroxy-6-methyl-7-methylidene-2-(nona-1,3-dien-1-yl)pyrano[2,3-c]pyrrole-4,5-dione

3-hydroxy-6-methyl-7-methylidene-2-(nona-1,3-dien-1-yl)pyrano[2,3-c]pyrrole-4,5-dione

C18H21NO4 (315.1471)


   

4,17-dimethoxy-11-azatetracyclo[9.7.0.0¹,¹⁴.0²,⁷]octadeca-2(7),3,5,15-tetraen-5-ol

4,17-dimethoxy-11-azatetracyclo[9.7.0.0¹,¹⁴.0²,⁷]octadeca-2(7),3,5,15-tetraen-5-ol

C19H25NO3 (315.1834)


   

7-(2h-1,3-benzodioxol-5-yl)-1-(piperidin-1-yl)hept-6-en-1-one

7-(2h-1,3-benzodioxol-5-yl)-1-(piperidin-1-yl)hept-6-en-1-one

C19H25NO3 (315.1834)


   

(2e)-3-(4-hydroxy-5-methoxycyclohexa-2,4-dien-1-yl)-n-[2-(4-hydroxyphenyl)ethyl]prop-2-enimidic acid

(2e)-3-(4-hydroxy-5-methoxycyclohexa-2,4-dien-1-yl)-n-[2-(4-hydroxyphenyl)ethyl]prop-2-enimidic acid

C18H21NO4 (315.1471)


   

5,17-dimethoxy-11-azatetracyclo[9.7.0.0¹,¹⁴.0²,⁷]octadeca-2(7),3,5,15-tetraen-4-ol

5,17-dimethoxy-11-azatetracyclo[9.7.0.0¹,¹⁴.0²,⁷]octadeca-2(7),3,5,15-tetraen-4-ol

C19H25NO3 (315.1834)


   

(1r,7ar)-1-hydroxy-7-({[(2s)-2-hydroxy-2-[(1r)-1-hydroxyethyl]-3-methylbutanoyl]oxy}methyl)-2,3,5,7a-tetrahydro-1h-pyrrolizin-4-ium-4-olate

(1r,7ar)-1-hydroxy-7-({[(2s)-2-hydroxy-2-[(1r)-1-hydroxyethyl]-3-methylbutanoyl]oxy}methyl)-2,3,5,7a-tetrahydro-1h-pyrrolizin-4-ium-4-olate

C15H25NO6 (315.1682)


   

10',11'-dimethoxy-5'-methyl-5'-azaspiro[cyclohexane-1,2'-tricyclo[6.3.1.0⁴,¹²]dodecane]-1'(11'),3,8'(12'),9'-tetraen-2-ol

10',11'-dimethoxy-5'-methyl-5'-azaspiro[cyclohexane-1,2'-tricyclo[6.3.1.0⁴,¹²]dodecane]-1'(11'),3,8'(12'),9'-tetraen-2-ol

C19H25NO3 (315.1834)


   

(1s)-1-(3-carbamimidamidopropyl)-2h,3h,4h,9h-pyrido[3,4-b]indole-1-carboxylic acid

(1s)-1-(3-carbamimidamidopropyl)-2h,3h,4h,9h-pyrido[3,4-b]indole-1-carboxylic acid

C16H21N5O2 (315.1695)


   

(6s)-3-methoxy-16,18-dioxa-10-azapentacyclo[11.7.0.0²,⁶.0⁶,¹⁰.0¹⁵,¹⁹]icosa-1(20),2,13,15(19)-tetraen-4-ol

(6s)-3-methoxy-16,18-dioxa-10-azapentacyclo[11.7.0.0²,⁶.0⁶,¹⁰.0¹⁵,¹⁹]icosa-1(20),2,13,15(19)-tetraen-4-ol

C18H21NO4 (315.1471)


   

[(7r,7ar)-7-hydroxy-5,6,7,7a-tetrahydro-3h-pyrrolizin-1-yl]methyl (2r)-2,3-dihydroxy-2-[(1r)-1-hydroxyethyl]-3-methylbutanoate

[(7r,7ar)-7-hydroxy-5,6,7,7a-tetrahydro-3h-pyrrolizin-1-yl]methyl (2r)-2,3-dihydroxy-2-[(1r)-1-hydroxyethyl]-3-methylbutanoate

C15H25NO6 (315.1682)


   

6-hydroxy-10',11'-dimethoxy-5'-azaspiro[cyclohexane-1,2'-tricyclo[6.3.1.0⁴,¹²]dodecane]-1'(11'),2,8'(12'),9'-tetraen-4-one

6-hydroxy-10',11'-dimethoxy-5'-azaspiro[cyclohexane-1,2'-tricyclo[6.3.1.0⁴,¹²]dodecane]-1'(11'),2,8'(12'),9'-tetraen-4-one

C18H21NO4 (315.1471)


   

4-methoxy-3-methyl-5-[(2r,3s,4e,6r)-3-methyl-5-oxa-10-azatricyclo[8.3.0.0²,⁶]trideca-1(13),11-dien-4-ylidene]furan-2-one

4-methoxy-3-methyl-5-[(2r,3s,4e,6r)-3-methyl-5-oxa-10-azatricyclo[8.3.0.0²,⁶]trideca-1(13),11-dien-4-ylidene]furan-2-one

C18H21NO4 (315.1471)


   

(3s,11ar)-8,9-dihydroxy-3-methoxy-,,2,3,4,11-hexahydro-h-5a-azatetraphen-6-one

(3s,11ar)-8,9-dihydroxy-3-methoxy-,,2,3,4,11-hexahydro-h-5a-azatetraphen-6-one

C18H21NO4 (315.1471)


   

(1r,12s,14r)-9-hydroxy-4-methyl-11-oxa-4-azatetracyclo[8.6.1.0¹,¹².0⁶,¹⁷]heptadeca-6,8,10(17),15-tetraen-14-yl acetate

(1r,12s,14r)-9-hydroxy-4-methyl-11-oxa-4-azatetracyclo[8.6.1.0¹,¹².0⁶,¹⁷]heptadeca-6,8,10(17),15-tetraen-14-yl acetate

C18H21NO4 (315.1471)


   

(1s,4s,4'r)-10',11'-dimethoxy-5'-methyl-5'-azaspiro[cyclohexane-1,2'-tricyclo[6.3.1.0⁴,¹²]dodecane]-1'(11'),2,8'(12'),9'-tetraen-4-ol

(1s,4s,4'r)-10',11'-dimethoxy-5'-methyl-5'-azaspiro[cyclohexane-1,2'-tricyclo[6.3.1.0⁴,¹²]dodecane]-1'(11'),2,8'(12'),9'-tetraen-4-ol

C19H25NO3 (315.1834)


   

2-[5-(acetyloxy)-1-methyl-2,3,5,6,7,7a-hexahydroindol-7-yl]benzoic acid

2-[5-(acetyloxy)-1-methyl-2,3,5,6,7,7a-hexahydroindol-7-yl]benzoic acid

C18H21NO4 (315.1471)


   

(1s,17s)-5,17-dimethoxy-11-azatetracyclo[9.7.0.0¹,¹⁴.0²,⁷]octadeca-2(7),3,5,14-tetraen-4-ol

(1s,17s)-5,17-dimethoxy-11-azatetracyclo[9.7.0.0¹,¹⁴.0²,⁷]octadeca-2(7),3,5,14-tetraen-4-ol

C19H25NO3 (315.1834)


   

(2e)-7-(2h-1,3-benzodioxol-5-yl)-1-(piperidin-1-yl)hept-2-en-1-one

(2e)-7-(2h-1,3-benzodioxol-5-yl)-1-(piperidin-1-yl)hept-2-en-1-one

C19H25NO3 (315.1834)


   

(1s,15s,16s)-5-hydroxy-4-methoxy-9-azatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-2(7),3,5,12-tetraen-15-yl acetate

(1s,15s,16s)-5-hydroxy-4-methoxy-9-azatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-2(7),3,5,12-tetraen-15-yl acetate

C18H21NO4 (315.1471)


   

(2r,3r)-2-{[(2s)-2-amino-1-hydroxy-3-methylbutylidene]amino}-3-hydroxy-3-[(3s,5r)-7-oxo-4-oxa-1-azabicyclo[3.2.0]heptan-3-yl]propanoic acid

(2r,3r)-2-{[(2s)-2-amino-1-hydroxy-3-methylbutylidene]amino}-3-hydroxy-3-[(3s,5r)-7-oxo-4-oxa-1-azabicyclo[3.2.0]heptan-3-yl]propanoic acid

C13H21N3O6 (315.143)


   

(1s,5r,13r,14s,17s)-10-methoxy-4-methyl-12-oxa-4-azapentacyclo[9.6.1.0¹,¹³.0⁵,¹⁷.0⁷,¹⁸]octadeca-7,9,11(18),15-tetraene-14,17-diol

(1s,5r,13r,14s,17s)-10-methoxy-4-methyl-12-oxa-4-azapentacyclo[9.6.1.0¹,¹³.0⁵,¹⁷.0⁷,¹⁸]octadeca-7,9,11(18),15-tetraene-14,17-diol

C18H21NO4 (315.1471)


   

5-hydroxy-4-methoxy-9-azatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-2(7),3,5,12-tetraen-15-yl acetate

5-hydroxy-4-methoxy-9-azatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-2(7),3,5,12-tetraen-15-yl acetate

C18H21NO4 (315.1471)


   

(1s,9ar)-octahydro-1h-quinolizin-1-ylmethyl (2e)-3-(4-hydroxyphenyl)prop-2-enoate

(1s,9ar)-octahydro-1h-quinolizin-1-ylmethyl (2e)-3-(4-hydroxyphenyl)prop-2-enoate

C19H25NO3 (315.1834)


   

(1s,7ar)-1-hydroxy-7-({[(2s)-2-hydroxy-2-[(1r)-1-hydroxyethyl]-3-methylbutanoyl]oxy}methyl)-2,3,5,7a-tetrahydro-1h-pyrrolizin-4-ium-4-olate

(1s,7ar)-1-hydroxy-7-({[(2s)-2-hydroxy-2-[(1r)-1-hydroxyethyl]-3-methylbutanoyl]oxy}methyl)-2,3,5,7a-tetrahydro-1h-pyrrolizin-4-ium-4-olate

C15H25NO6 (315.1682)


   

(2s)-1-(4-methoxy-1-methyl-2-oxoquinolin-3-yl)-3-methylbut-3-en-2-yl acetate

(2s)-1-(4-methoxy-1-methyl-2-oxoquinolin-3-yl)-3-methylbut-3-en-2-yl acetate

C18H21NO4 (315.1471)


   

(2z,4e)-5-{3-[(2e)-4-hydroxy-4-methylpent-2-en-1-yl]-3-methyloxiran-2-yl}-3-methyl-1-(1h-pyrrol-2-yl)penta-2,4-dien-1-one

(2z,4e)-5-{3-[(2e)-4-hydroxy-4-methylpent-2-en-1-yl]-3-methyloxiran-2-yl}-3-methyl-1-(1h-pyrrol-2-yl)penta-2,4-dien-1-one

C19H25NO3 (315.1834)


   

(2s)-2-{[(2s)-2-amino-1-hydroxy-3-methylbutylidene]amino}-3-hydroxy-3-[(3r,5s)-7-oxo-4-oxa-1-azabicyclo[3.2.0]heptan-3-yl]propanoic acid

(2s)-2-{[(2s)-2-amino-1-hydroxy-3-methylbutylidene]amino}-3-hydroxy-3-[(3r,5s)-7-oxo-4-oxa-1-azabicyclo[3.2.0]heptan-3-yl]propanoic acid

C13H21N3O6 (315.143)


   

(1r,9s,10s)-3-hydroxy-4,12-dimethoxy-17-azatetracyclo[7.5.3.0¹,¹⁰.0²,⁷]heptadeca-2,4,6,11-tetraen-13-one

(1r,9s,10s)-3-hydroxy-4,12-dimethoxy-17-azatetracyclo[7.5.3.0¹,¹⁰.0²,⁷]heptadeca-2,4,6,11-tetraen-13-one

C18H21NO4 (315.1471)


   

(1s,5r,13r,14r,17r)-10,14-dimethoxy-4-methyl-12-oxa-4-azapentacyclo[9.6.1.0¹,¹³.0⁵,¹⁷.0⁷,¹⁸]octadeca-7,9,11(18)-triene

(1s,5r,13r,14r,17r)-10,14-dimethoxy-4-methyl-12-oxa-4-azapentacyclo[9.6.1.0¹,¹³.0⁵,¹⁷.0⁷,¹⁸]octadeca-7,9,11(18)-triene

C19H25NO3 (315.1834)


   

3-(4-hydroxy-3-methoxyphenyl)-n-[2-(4-hydroxyphenyl)ethyl]propanimidic acid

3-(4-hydroxy-3-methoxyphenyl)-n-[2-(4-hydroxyphenyl)ethyl]propanimidic acid

C18H21NO4 (315.1471)


   

(1r,7ar)-1-hydroxy-7-({[(2s)-2-hydroxy-2-[(1s)-1-hydroxyethyl]-3-methylbutanoyl]oxy}methyl)-2,3,5,7a-tetrahydro-1h-pyrrolizin-4-ium-4-olate

(1r,7ar)-1-hydroxy-7-({[(2s)-2-hydroxy-2-[(1s)-1-hydroxyethyl]-3-methylbutanoyl]oxy}methyl)-2,3,5,7a-tetrahydro-1h-pyrrolizin-4-ium-4-olate

C15H25NO6 (315.1682)


   

(14s)-10-methoxy-4-methyl-12-oxa-4-azapentacyclo[9.6.1.0¹,¹³.0⁵,¹⁷.0⁷,¹⁸]octadeca-7,9,11(18),15-tetraene-14,17-diol

(14s)-10-methoxy-4-methyl-12-oxa-4-azapentacyclo[9.6.1.0¹,¹³.0⁵,¹⁷.0⁷,¹⁸]octadeca-7,9,11(18),15-tetraene-14,17-diol

C18H21NO4 (315.1471)


   

(1r,4s,7ar)-1-hydroxy-7-({[(2r)-2-hydroxy-2-[(1s)-1-hydroxyethyl]-3-methylbutanoyl]oxy}methyl)-2,3,5,7a-tetrahydro-1h-pyrrolizin-4-ium-4-olate

(1r,4s,7ar)-1-hydroxy-7-({[(2r)-2-hydroxy-2-[(1s)-1-hydroxyethyl]-3-methylbutanoyl]oxy}methyl)-2,3,5,7a-tetrahydro-1h-pyrrolizin-4-ium-4-olate

C15H25NO6 (315.1682)


   

(1s,13r,15r)-9,15-dimethoxy-5,7-dioxa-12-azapentacyclo[10.5.2.0¹,¹³.0²,¹⁰.0⁴,⁸]nonadeca-2,4(8),9,16-tetraene

(1s,13r,15r)-9,15-dimethoxy-5,7-dioxa-12-azapentacyclo[10.5.2.0¹,¹³.0²,¹⁰.0⁴,⁸]nonadeca-2,4(8),9,16-tetraene

C18H21NO4 (315.1471)


   

1-(4-methoxy-1-methyl-2-oxoquinolin-3-yl)-3-methylbut-3-en-2-yl acetate

1-(4-methoxy-1-methyl-2-oxoquinolin-3-yl)-3-methylbut-3-en-2-yl acetate

C18H21NO4 (315.1471)


   

6-amino-10,10-dihydroxy-4-[(c-hydroxycarbonimidoyloxy)methyl]-2-imino-1h,3h,3ah,4h,8h,9h-pyrrolo[1,2-c]purin-5-ium-5-olate

6-amino-10,10-dihydroxy-4-[(c-hydroxycarbonimidoyloxy)methyl]-2-imino-1h,3h,3ah,4h,8h,9h-pyrrolo[1,2-c]purin-5-ium-5-olate

C10H17N7O5 (315.1291)


   

n-{3-[(4z)-2-hydroxy-1-[(1e)-2-(4-hydroxyphenyl)ethenyl]-5-oxoimidazol-4-ylidene]propyl}guanidine

n-{3-[(4z)-2-hydroxy-1-[(1e)-2-(4-hydroxyphenyl)ethenyl]-5-oxoimidazol-4-ylidene]propyl}guanidine

C15H17N5O3 (315.1331)


   

4,8-dimethoxy-8-(3-methylbutan-2-yl)furo[2,3-b]quinolin-7-one

4,8-dimethoxy-8-(3-methylbutan-2-yl)furo[2,3-b]quinolin-7-one

C18H21NO4 (315.1471)


   

n-(3-{2-hydroxy-1-[2-(4-hydroxyphenyl)ethenyl]-5-oxoimidazol-4-ylidene}propyl)guanidine

n-(3-{2-hydroxy-1-[2-(4-hydroxyphenyl)ethenyl]-5-oxoimidazol-4-ylidene}propyl)guanidine

C15H17N5O3 (315.1331)


   

(1r,7as)-1-hydroxy-7-({[(2r)-2-hydroxy-2-[(1s)-1-hydroxyethyl]-3-methylbutanoyl]oxy}methyl)-2,3,5,7a-tetrahydro-1h-pyrrolizin-4-ium-4-olate

(1r,7as)-1-hydroxy-7-({[(2r)-2-hydroxy-2-[(1s)-1-hydroxyethyl]-3-methylbutanoyl]oxy}methyl)-2,3,5,7a-tetrahydro-1h-pyrrolizin-4-ium-4-olate

C15H25NO6 (315.1682)


   

(2e,4e)-5-(6-methoxy-2h-1,3-benzodioxol-5-yl)-1-(piperidin-1-yl)penta-2,4-dien-1-one

(2e,4e)-5-(6-methoxy-2h-1,3-benzodioxol-5-yl)-1-(piperidin-1-yl)penta-2,4-dien-1-one

C18H21NO4 (315.1471)


   

10-methoxy-4-methyl-12-oxa-4-azapentacyclo[9.6.1.0¹,¹³.0⁵,¹⁷.0⁷,¹⁸]octadeca-7,9,11(18),15-tetraene-14,17-diol

10-methoxy-4-methyl-12-oxa-4-azapentacyclo[9.6.1.0¹,¹³.0⁵,¹⁷.0⁷,¹⁸]octadeca-7,9,11(18),15-tetraene-14,17-diol

C18H21NO4 (315.1471)


   

(1s)-1-[(3-hydroxy-4-methoxyphenyl)methyl]-7-methoxy-1,2,3,4-tetrahydroisoquinolin-6-ol

(1s)-1-[(3-hydroxy-4-methoxyphenyl)methyl]-7-methoxy-1,2,3,4-tetrahydroisoquinolin-6-ol

C18H21NO4 (315.1471)


   

(3s,4r)-5-hydroxy-3-{4-[(3-methylbut-3-en-1-yl)oxy]phenyl}-4-(2-methylpropyl)-3,4-dihydropyrrol-2-one

(3s,4r)-5-hydroxy-3-{4-[(3-methylbut-3-en-1-yl)oxy]phenyl}-4-(2-methylpropyl)-3,4-dihydropyrrol-2-one

C19H25NO3 (315.1834)


   

8,9-dihydroxy-3-methoxy-,,2,3,4,11-hexahydro-h-5a-azatetraphen-6-one

8,9-dihydroxy-3-methoxy-,,2,3,4,11-hexahydro-h-5a-azatetraphen-6-one

C18H21NO4 (315.1471)


   

(2e,5s,9s)-15,16-dimethoxy-18-oxa-10-azatetracyclo[7.7.1.1²,⁸.0¹³,¹⁷]octadeca-1(16),2,7,13(17),14-pentaen-5-ol

(2e,5s,9s)-15,16-dimethoxy-18-oxa-10-azatetracyclo[7.7.1.1²,⁸.0¹³,¹⁷]octadeca-1(16),2,7,13(17),14-pentaen-5-ol

C18H21NO4 (315.1471)


   

n-[2-(3,4-dimethoxyphenyl)-2-methoxyethyl]benzenecarboximidic acid

n-[2-(3,4-dimethoxyphenyl)-2-methoxyethyl]benzenecarboximidic acid

C18H21NO4 (315.1471)